Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-590-3p AAK1 -0.36 0.34337 0.17 0.82132 PITA -0.12 0.00148 NA
2 hsa-miR-590-3p AASS -0.36 0.34337 0.15 0.73559 MirTarget; miRanda -0.24 0.0002 NA
3 hsa-miR-590-3p ABAT -0.36 0.34337 0.49 0.52425 PITA; miRanda -0.21 0.01796 NA
4 hsa-miR-590-3p ABCA1 -0.36 0.34337 0.08 0.9174 miRanda -0.34 0 NA
5 hsa-miR-590-3p ABCA4 -0.36 0.34337 -0.18 0.77586 miRanda -0.24 0.04432 NA
6 hsa-miR-590-3p ABCA6 -0.36 0.34337 0.37 0.44279 MirTarget; miRanda -0.72 0 NA
7 hsa-miR-590-3p ABCA8 -0.36 0.34337 0.91 0.15982 miRanda -1.13 0 NA
8 hsa-miR-590-3p ABCA9 -0.36 0.34337 0.32 0.49728 miRanda -0.65 0 NA
9 hsa-miR-590-3p ABCB4 -0.36 0.34337 0.44 0.15356 miRanda -0.39 0 NA
10 hsa-miR-590-3p ABCC4 -0.36 0.34337 0 0.99533 mirMAP -0.19 0.0024 NA
11 hsa-miR-590-3p ABCC9 -0.36 0.34337 0.42 0.26893 miRanda; mirMAP -0.72 0 NA
12 hsa-miR-590-3p ABCD2 -0.36 0.34337 -0.28 0.53738 MirTarget; miRanda; mirMAP -0.32 0.00073 NA
13 hsa-miR-590-3p ABI3BP -0.36 0.34337 0.02 0.97029 miRanda -0.67 0 NA
14 hsa-miR-590-3p ABL2 -0.36 0.34337 0.22 0.76756 PITA; mirMAP; miRNATAP -0.13 0 NA
15 hsa-miR-590-3p ACSL1 -0.36 0.34337 0.03 0.96979 miRanda -0.13 0.01819 NA
16 hsa-miR-590-3p ACSL4 -0.36 0.34337 0.06 0.95013 MirTarget; PITA; miRanda; mirMAP -0.12 0.00663 NA
17 hsa-miR-590-3p ACSS3 -0.36 0.34337 0.43 0.34589 miRanda -0.85 0 NA
18 hsa-miR-590-3p ACTC1 -0.36 0.34337 0.88 0.12195 miRanda -1.06 0 NA
19 hsa-miR-590-3p ACTG2 -0.36 0.34337 0.77 0.43269 miRanda -1.05 0 NA
20 hsa-miR-590-3p ACTN1 -0.36 0.34337 -0.12 0.92597 miRanda; miRNATAP -0.17 0 NA
21 hsa-miR-590-3p ACVR1 -0.36 0.34337 0.11 0.87891 miRanda -0.13 0 NA
22 hsa-miR-590-3p ADAM12 -0.36 0.34337 0.13 0.85388 mirMAP -0.72 0 NA
23 hsa-miR-590-3p ADAM19 -0.36 0.34337 0.21 0.80346 miRanda -0.32 0 NA
24 hsa-miR-590-3p ADAM22 -0.36 0.34337 0.01 0.98433 MirTarget; PITA; miRanda; mirMAP -0.28 0.00121 NA
25 hsa-miR-590-3p ADAM23 -0.36 0.34337 0.58 0.18053 miRanda -0.88 0 NA
26 hsa-miR-590-3p ADAM33 -0.36 0.34337 0.45 0.33597 miRanda -0.88 0 NA
27 hsa-miR-590-3p ADAMTS1 -0.36 0.34337 0.2 0.78343 miRanda -0.42 0 NA
28 hsa-miR-590-3p ADAMTS14 -0.36 0.34337 0.04 0.93697 miRanda -0.26 0 NA
29 hsa-miR-590-3p ADAMTS16 -0.36 0.34337 0.12 0.81651 miRanda; mirMAP -0.93 0 NA
30 hsa-miR-590-3p ADAMTS18 -0.36 0.34337 0.69 0.21276 PITA; miRanda; miRNATAP -0.86 0 NA
31 hsa-miR-590-3p ADAMTS19 -0.36 0.34337 0.36 0.66296 PITA; miRanda; mirMAP; miRNATAP -0.39 0.00716 NA
32 hsa-miR-590-3p ADAMTS3 -0.36 0.34337 0.51 0.09131 miRanda; mirMAP -0.53 0 NA
33 hsa-miR-590-3p ADAMTS5 -0.36 0.34337 0.11 0.78245 PITA; miRanda; miRNATAP -0.34 0 NA
34 hsa-miR-590-3p ADAMTS6 -0.36 0.34337 0.44 0.13768 miRanda -0.4 0 NA
35 hsa-miR-590-3p ADAMTS8 -0.36 0.34337 0.28 0.51524 miRanda -0.66 0 NA
36 hsa-miR-590-3p ADAMTS9 -0.36 0.34337 -0.01 0.98367 miRanda -0.23 5.0E-5 NA
37 hsa-miR-590-3p ADAMTSL1 -0.36 0.34337 0.27 0.50351 miRanda; mirMAP -0.62 0 NA
38 hsa-miR-590-3p ADAMTSL3 -0.36 0.34337 0.82 0.07321 miRanda -1.03 0 NA
39 hsa-miR-590-3p ADARB1 -0.36 0.34337 -0.09 0.88168 miRanda; mirMAP -0.18 2.0E-5 NA
40 hsa-miR-590-3p ADCY2 -0.36 0.34337 0.6 0.13607 mirMAP -0.82 0 NA
41 hsa-miR-590-3p ADCYAP1 -0.36 0.34337 0.77 0.16711 MirTarget; PITA; miRanda; miRNATAP -1.04 0 NA
42 hsa-miR-590-3p ADH1A -0.36 0.34337 0.54 0.4822 miRanda -0.33 0.00577 NA
43 hsa-miR-590-3p ADH1B -0.36 0.34337 0.51 0.49361 miRanda; mirMAP -0.93 0 NA
44 hsa-miR-590-3p ADIPOQ -0.36 0.34337 -0.14 0.89057 PITA; miRanda; mirMAP -1.02 0 NA
45 hsa-miR-590-3p ADRB2 -0.36 0.34337 0.13 0.73444 MirTarget; PITA; miRanda -0.48 0 NA
46 hsa-miR-590-3p AFAP1 -0.36 0.34337 0.04 0.96403 PITA; miRanda; miRNATAP -0.21 0 NA
47 hsa-miR-590-3p AFF2 -0.36 0.34337 0.4 0.47466 PITA; miRanda; mirMAP; miRNATAP -0.29 0.00541 NA
48 hsa-miR-590-3p AFF3 -0.36 0.34337 0.43 0.25658 PITA; miRanda; mirMAP; miRNATAP -0.63 0 NA
49 hsa-miR-590-3p AGTR1 -0.36 0.34337 0.61 0.3376 miRanda -1.24 0 NA
50 hsa-miR-590-3p AHNAK -0.36 0.34337 0.18 0.89868 miRanda -0.21 8.0E-5 NA
51 hsa-miR-590-3p AK5 -0.36 0.34337 0.55 0.27754 miRanda; mirMAP -0.54 0 NA
52 hsa-miR-590-3p AKAP11 -0.36 0.34337 0.5 0.6075 MirTarget; miRanda; miRNATAP -0.1 0.00354 NA
53 hsa-miR-590-3p AKAP12 -0.36 0.34337 0.5 0.5257 miRanda; mirMAP -0.79 0 NA
54 hsa-miR-590-3p AKAP13 -0.36 0.34337 0.05 0.96485 PITA; miRanda; mirMAP -0.12 0.00071 NA
55 hsa-miR-590-3p AKAP2 -0.36 0.34337 0.41 0.5776 mirMAP -0.35 0 NA
56 hsa-miR-590-3p AKAP6 -0.36 0.34337 0.25 0.43037 MirTarget; PITA; miRanda; mirMAP -0.42 0 NA
57 hsa-miR-106a-5p AKT3 0.02 0.97734 0.4 0.44923 miRNATAP -0.55 0 NA
58 hsa-miR-106b-5p AKT3 -0.3 0.80498 0.4 0.44923 miRNATAP -0.91 0 NA
59 hsa-miR-107 AKT3 0.03 0.98456 0.4 0.44923 PITA; miRanda -0.55 0.00017 NA
60 hsa-miR-1275 AKT3 -0.74 0.05346 0.4 0.44923 PITA -0.27 0 NA
61 hsa-miR-140-5p AKT3 -0.28 0.72738 0.4 0.44923 miRanda -0.29 0.02297 NA
62 hsa-miR-142-3p AKT3 -0.33 0.82659 0.4 0.44923 miRanda -0.2 0.00627 NA
63 hsa-miR-15a-5p AKT3 -0.18 0.85918 0.4 0.44923 miRNAWalker2 validate; miRTarBase; miRNATAP -0.72 0 NA
64 hsa-miR-15b-5p AKT3 -0.27 0.81448 0.4 0.44923 miRNATAP -0.67 0 NA
65 hsa-miR-16-5p AKT3 -0.16 0.90258 0.4 0.44923 miRNAWalker2 validate; miRTarBase; miRNATAP -0.75 0 NA
66 hsa-miR-17-3p AKT3 0.19 0.88899 0.4 0.44923 miRNATAP -0.52 0 NA
67 hsa-miR-17-5p AKT3 -0.19 0.89387 0.4 0.44923 TargetScan; miRNATAP -0.63 0 NA
68 hsa-miR-181b-5p AKT3 0.08 0.94924 0.4 0.44923 miRNATAP -0.27 0.00963 NA
69 hsa-miR-20a-5p AKT3 -0.21 0.87528 0.4 0.44923 miRNATAP -0.53 0 NA
70 hsa-miR-28-3p AKT3 -0.12 0.95041 0.4 0.44923 miRNATAP -0.52 0.00719 NA
71 hsa-miR-29a-3p AKT3 -0.03 0.98696 0.4 0.44923 miRNATAP -0.81 0 NA
72 hsa-miR-29b-3p AKT3 -0.11 0.93739 0.4 0.44923 miRNATAP -0.68 0 26512921 MicroRNA 29B mir 29b regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3
73 hsa-miR-32-3p AKT3 -0.74 0.01927 0.4 0.44923 mirMAP -0.56 0 NA
74 hsa-miR-320a AKT3 -0.31 0.82473 0.4 0.44923 PITA; miRanda; miRNATAP -0.33 0.00138 NA
75 hsa-miR-320b AKT3 -0.21 0.8173 0.4 0.44923 PITA; miRanda; miRNATAP -0.25 0.00855 NA
76 hsa-miR-320c AKT3 0.06 0.84497 0.4 0.44923 PITA; miRanda; miRNATAP -0.17 0.01525 NA
77 hsa-miR-335-3p AKT3 -0.07 0.94833 0.4 0.44923 mirMAP -0.58 0 NA
78 hsa-miR-33a-3p AKT3 -0.32 0.2319 0.4 0.44923 mirMAP -0.49 0 NA
79 hsa-miR-340-5p AKT3 0 0.99856 0.4 0.44923 mirMAP -0.28 0.006 NA
80 hsa-miR-362-3p AKT3 -0.75 0.0079 0.4 0.44923 miRanda -0.42 0 NA
81 hsa-miR-362-5p AKT3 -0.33 0.57644 0.4 0.44923 PITA; TargetScan; miRNATAP -0.52 0 NA
82 hsa-miR-369-3p AKT3 -0.27 0.47468 0.4 0.44923 mirMAP -0.23 0.00901 NA
83 hsa-miR-374a-5p AKT3 -0.12 0.88361 0.4 0.44923 mirMAP -0.58 0 NA
84 hsa-miR-374b-5p AKT3 -0.02 0.98427 0.4 0.44923 mirMAP -0.68 0 NA
85 hsa-miR-421 AKT3 0.04 0.90972 0.4 0.44923 miRanda; mirMAP -0.46 0 NA
86 hsa-miR-424-5p AKT3 0.1 0.92161 0.4 0.44923 miRNATAP -0.24 0.00104 26315541 Silencing Akt3 and E2F3 by siRNA pheno-copied the effect of ectopic miR-424 on HCC growth; Whereas overexpression of Akt3 and E2F3 attenuated the effect of miR-424 on HCC growth
87 hsa-miR-501-3p AKT3 -0.62 0.47515 0.4 0.44923 miRNATAP -0.5 0 NA
88 hsa-miR-502-3p AKT3 -0.41 0.42345 0.4 0.44923 miRNATAP -0.64 0 NA
89 hsa-miR-502-5p AKT3 -0.67 0.01174 0.4 0.44923 PITA; miRNATAP -0.41 0 NA
90 hsa-miR-505-3p AKT3 -0.29 0.71829 0.4 0.44923 mirMAP -0.77 0 22051041 We also find that Akt3 correlate inversely with miR-505 modulates drug sensitivity in MCF7-ADR
91 hsa-miR-539-5p AKT3 0.05 0.89401 0.4 0.44923 mirMAP; miRNATAP -0.19 0.0467 NA
92 hsa-miR-548o-3p AKT3 -0.24 0.33007 0.4 0.44923 mirMAP -0.31 8.0E-5 NA
93 hsa-miR-577 AKT3 -0.35 0.65798 0.4 0.44923 mirMAP -0.38 0 NA
94 hsa-miR-663b AKT3 -0.09 0.80614 0.4 0.44923 PITA -0.25 1.0E-5 NA
95 hsa-miR-769-5p AKT3 -0.27 0.66324 0.4 0.44923 PITA; miRNATAP -0.84 0 NA
96 hsa-miR-93-5p AKT3 -0.52 0.78234 0.4 0.44923 miRNATAP -0.76 0 NA
97 hsa-miR-590-3p ALDH1A3 -0.36 0.34337 0.52 0.46382 miRanda; mirMAP -0.56 0 NA
98 hsa-miR-590-3p ALDH1L2 -0.36 0.34337 0.37 0.45072 MirTarget; miRanda; mirMAP -0.38 0 NA
99 hsa-miR-590-3p ALOX15B -0.36 0.34337 0.06 0.90014 miRanda -0.31 0.01736 NA
100 hsa-miR-590-3p ALOX5AP -0.36 0.34337 0.06 0.92041 miRanda -0.32 0 NA
101 hsa-miR-590-3p ALPK3 -0.36 0.34337 0.17 0.79201 miRanda; mirMAP -0.36 0.00074 NA
102 hsa-miR-590-3p AMOTL1 -0.36 0.34337 0.43 0.5123 mirMAP -0.7 0 NA
103 hsa-miR-590-3p AMOTL2 -0.36 0.34337 0.28 0.74734 miRanda -0.17 2.0E-5 NA
104 hsa-miR-590-3p ANGPT1 -0.36 0.34337 0.11 0.73429 PITA; miRanda; mirMAP -0.61 0 NA
105 hsa-miR-590-3p ANGPT2 -0.36 0.34337 0.28 0.56688 miRanda -0.16 0.0007 NA
106 hsa-miR-590-3p ANGPTL1 -0.36 0.34337 0.76 0.1952 PITA; miRanda; mirMAP -1.27 0 NA
107 hsa-miR-590-3p ANK2 -0.36 0.34337 0.17 0.6895 MirTarget; PITA; miRanda -0.86 0 NA
108 hsa-miR-590-3p ANKDD1A -0.36 0.34337 -0.09 0.72562 PITA; miRanda -0.12 0.00596 NA
109 hsa-miR-590-3p ANKH -0.36 0.34337 0.34 0.75905 mirMAP; miRNATAP -0.13 0.00249 NA
110 hsa-miR-590-3p ANKRD29 -0.36 0.34337 0.44 0.20989 mirMAP -0.34 0.00023 NA
111 hsa-miR-590-3p ANKRD44 -0.36 0.34337 -0.12 0.68996 miRanda -0.34 0 NA
112 hsa-miR-590-3p ANKRD50 -0.36 0.34337 -0.07 0.91915 PITA; miRanda; mirMAP -0.22 0 NA
113 hsa-miR-590-3p ANKRD6 -0.36 0.34337 0.39 0.18773 miRanda; mirMAP -0.46 0 NA
114 hsa-miR-590-3p ANO1 -0.36 0.34337 0.26 0.76501 miRanda -0.23 0.01468 NA
115 hsa-miR-590-3p ANO2 -0.36 0.34337 -0.13 0.74125 miRanda -0.16 0.02281 NA
116 hsa-miR-590-3p ANO5 -0.36 0.34337 0.97 0.09806 miRanda; mirMAP -0.68 0 NA
117 hsa-miR-590-3p ANO6 -0.36 0.34337 -0 0.99967 MirTarget; miRanda; mirMAP -0.12 0.00254 NA
118 hsa-miR-590-3p ANTXR1 -0.36 0.34337 0.45 0.66855 miRanda; mirMAP -0.77 0 NA
119 hsa-miR-590-3p ANTXR2 -0.36 0.34337 -0.1 0.9213 PITA; miRanda; mirMAP; miRNATAP -0.12 0.01367 NA
120 hsa-miR-590-3p ANXA5 -0.36 0.34337 -0.13 0.90981 miRanda; mirMAP; miRNATAP -0.14 0.00015 NA
121 hsa-miR-590-3p AOX1 -0.36 0.34337 0.44 0.30921 miRanda -0.68 0 NA
122 hsa-miR-590-3p AP1S2 -0.36 0.34337 0.1 0.83884 miRanda; mirMAP -0.3 0 NA
123 hsa-miR-590-3p APBB1IP -0.36 0.34337 -0.28 0.52587 miRanda -0.34 7.0E-5 NA
124 hsa-miR-590-3p APC -0.36 0.34337 0.33 0.65377 PITA; miRanda; mirMAP; miRNATAP -0.1 0.00339 NA
125 hsa-miR-590-3p APCDD1L -0.36 0.34337 0.46 0.45652 miRanda -0.8 0 NA
126 hsa-miR-590-3p APLF -0.36 0.34337 0.1 0.77268 miRanda -0.16 0.00762 NA
127 hsa-miR-590-3p APOE -0.36 0.34337 0.01 0.99002 miRanda -0.49 1.0E-5 NA
128 hsa-miR-590-3p APOL4 -0.36 0.34337 -0.58 0.28305 miRanda; mirMAP -0.17 0.02568 NA
129 hsa-miR-590-3p AQP9 -0.36 0.34337 -0.21 0.70602 miRanda; mirMAP; miRNATAP -0.59 3.0E-5 NA
130 hsa-miR-590-3p AR -0.36 0.34337 0.37 0.52932 mirMAP; miRNATAP -0.86 0 NA
131 hsa-miR-590-3p ARAP3 -0.36 0.34337 0.27 0.69361 mirMAP -0.2 0.00066 NA
132 hsa-miR-590-3p ARHGAP10 -0.36 0.34337 0.25 0.61073 miRanda -0.31 7.0E-5 NA
133 hsa-miR-590-3p ARHGAP15 -0.36 0.34337 -0.34 0.25867 miRanda; mirMAP -0.34 1.0E-5 NA
134 hsa-miR-590-3p ARHGAP23 -0.36 0.34337 0.57 0.43351 miRanda -0.32 0 NA
135 hsa-miR-590-3p ARHGAP24 -0.36 0.34337 0.03 0.95242 miRanda; mirMAP -0.32 0 NA
136 hsa-miR-590-3p ARHGAP25 -0.36 0.34337 -0.25 0.58148 miRanda -0.28 2.0E-5 NA
137 hsa-miR-590-3p ARHGAP28 -0.36 0.34337 0.21 0.50428 mirMAP -0.43 0 NA
138 hsa-miR-590-3p ARHGAP29 -0.36 0.34337 0 0.9954 miRanda; mirMAP -0.19 0.00069 NA
139 hsa-miR-590-3p ARHGAP31 -0.36 0.34337 0.1 0.88148 miRanda; mirMAP; miRNATAP -0.39 0 NA
140 hsa-miR-590-3p ARHGEF15 -0.36 0.34337 0.06 0.89327 miRanda; mirMAP -0.37 0 NA
141 hsa-miR-590-3p ARHGEF6 -0.36 0.34337 -0.03 0.94812 miRanda; mirMAP -0.37 0 NA
142 hsa-miR-590-3p ARL10 -0.36 0.34337 0.45 0.17265 mirMAP -0.54 0 NA
143 hsa-miR-590-3p ARL15 -0.36 0.34337 0.13 0.82504 miRanda; mirMAP -0.21 0 NA
144 hsa-miR-590-3p ARMC9 -0.36 0.34337 0.08 0.88916 MirTarget; miRanda -0.23 0 NA
145 hsa-miR-590-3p ARMCX2 -0.36 0.34337 0.19 0.70988 miRanda -0.54 0 NA
146 hsa-miR-590-3p ARMCX3 -0.36 0.34337 0.12 0.89196 PITA; miRanda; mirMAP -0.18 0.00034 NA
147 hsa-miR-590-3p ARNT2 -0.36 0.34337 -0.1 0.85187 PITA; miRanda; miRNATAP -0.46 0 NA
148 hsa-miR-590-3p ARRDC3 -0.36 0.34337 -0.05 0.95914 mirMAP -0.16 4.0E-5 NA
149 hsa-miR-590-3p ARSB -0.36 0.34337 -0.17 0.77665 PITA; miRanda; mirMAP; miRNATAP -0.2 0 NA
150 hsa-miR-590-3p ASAP1 -0.36 0.34337 0.5 0.54961 MirTarget; miRanda; mirMAP -0.17 6.0E-5 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 349 1672 4.427e-52 2.06e-48
2 BIOLOGICAL ADHESION 250 1032 1.378e-48 3.206e-45
3 CARDIOVASCULAR SYSTEM DEVELOPMENT 207 788 7.389e-46 8.595e-43
4 CIRCULATORY SYSTEM DEVELOPMENT 207 788 7.389e-46 8.595e-43
5 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 297 1395 1.213e-45 1.128e-42
6 REGULATION OF CELL DIFFERENTIATION 306 1492 1.34e-43 1.039e-40
7 NEUROGENESIS 293 1402 2.567e-43 1.707e-40
8 VASCULATURE DEVELOPMENT 146 469 1.368e-41 7.956e-39
9 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 246 1142 2.152e-38 1.113e-35
10 CELL DEVELOPMENT 284 1426 7.939e-38 3.694e-35
11 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 227 1021 1.319e-37 5.578e-35
12 BLOOD VESSEL MORPHOGENESIS 120 364 4.971e-37 1.927e-34
13 LOCOMOTION 238 1114 1.664e-36 5.955e-34
14 TISSUE DEVELOPMENT 292 1518 5.135e-36 1.707e-33
15 REGULATION OF CELL DEVELOPMENT 191 836 3.063e-33 9.5e-31
16 POSITIVE REGULATION OF CELL DIFFERENTIATION 189 823 3.321e-33 9.659e-31
17 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 250 1275 5.137e-32 1.406e-29
18 CELL MOTILITY 188 835 7.734e-32 1.894e-29
19 LOCALIZATION OF CELL 188 835 7.734e-32 1.894e-29
20 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 175 750 1.179e-31 2.742e-29
21 REGULATION OF CELLULAR COMPONENT MOVEMENT 178 771 1.398e-31 3.097e-29
22 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 205 983 7.142e-30 1.511e-27
23 REGULATION OF NEURON DIFFERENTIATION 140 554 3.769e-29 7.625e-27
24 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 133 513 6.613e-29 1.282e-26
25 RESPONSE TO ENDOGENOUS STIMULUS 262 1450 1.095e-27 2.039e-25
26 ORGAN MORPHOGENESIS 178 841 9.587e-27 1.716e-24
27 NEURON DIFFERENTIATION 182 874 1.883e-26 3.244e-24
28 CELLULAR COMPONENT MORPHOGENESIS 185 900 3.578e-26 5.946e-24
29 HEART DEVELOPMENT 120 466 7.029e-26 1.128e-23
30 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 199 1008 8.244e-26 1.279e-23
31 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 192 957 8.534e-26 1.281e-23
32 ANGIOGENESIS 90 293 1.697e-25 2.468e-23
33 POSITIVE REGULATION OF RESPONSE TO STIMULUS 315 1929 1.87e-25 2.637e-23
34 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 243 1360 6.324e-25 8.655e-23
35 POSITIVE REGULATION OF LOCOMOTION 110 420 1.878e-24 2.497e-22
36 TISSUE MORPHOGENESIS 127 533 5.231e-24 6.761e-22
37 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 166 801 6.303e-24 7.926e-22
38 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 277 1656 7.09e-24 8.681e-22
39 REGULATION OF NEURON PROJECTION DEVELOPMENT 107 408 7.282e-24 8.688e-22
40 CELL CELL ADHESION 138 608 7.519e-24 8.746e-22
41 REGULATION OF CELL PROLIFERATION 256 1496 1.839e-23 2.087e-21
42 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 298 1848 3.889e-23 4.309e-21
43 POSITIVE REGULATION OF CELL DEVELOPMENT 115 472 1.119e-22 1.211e-20
44 REGULATION OF TRANSPORT 291 1804 1.348e-22 1.425e-20
45 RESPONSE TO OXYGEN CONTAINING COMPOUND 239 1381 1.467e-22 1.483e-20
46 REGULATION OF CELL MORPHOGENESIS 127 552 1.446e-22 1.483e-20
47 REGULATION OF PHOSPHORUS METABOLIC PROCESS 268 1618 1.908e-22 1.889e-20
48 EXTRACELLULAR STRUCTURE ORGANIZATION 87 304 2.353e-22 2.281e-20
49 REGULATION OF CELL PROJECTION ORGANIZATION 127 558 3.956e-22 3.757e-20
50 REGULATION OF CELL ADHESION 137 629 6.37e-22 5.928e-20
51 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 108 437 7.09e-22 6.469e-20
52 CENTRAL NERVOUS SYSTEM DEVELOPMENT 170 872 1.681e-21 1.504e-19
53 SKELETAL SYSTEM DEVELOPMENT 110 455 1.877e-21 1.648e-19
54 TAXIS 111 464 2.977e-21 2.566e-19
55 EPITHELIUM DEVELOPMENT 178 945 8.453e-21 7.151e-19
56 REGULATION OF SYSTEM PROCESS 116 507 1.717e-20 1.427e-18
57 SYNAPSE ORGANIZATION 54 145 4.433e-20 3.543e-18
58 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 188 1036 4.493e-20 3.543e-18
59 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 188 1036 4.493e-20 3.543e-18
60 RESPONSE TO WOUNDING 123 563 6.816e-20 5.286e-18
61 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 156 799 7.511e-20 5.729e-18
62 NEGATIVE REGULATION OF CELL COMMUNICATION 206 1192 2.165e-19 1.625e-17
63 TUBE DEVELOPMENT 120 552 2.992e-19 2.209e-17
64 CIRCULATORY SYSTEM PROCESS 91 366 8.448e-19 6.005e-17
65 POSITIVE REGULATION OF CELL COMMUNICATION 246 1532 8.517e-19 6.005e-17
66 NEURON PROJECTION DEVELOPMENT 118 545 8.407e-19 6.005e-17
67 CELL CELL SIGNALING 149 767 8.695e-19 6.038e-17
68 NEURON DEVELOPMENT 138 687 9.116e-19 6.238e-17
69 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 138 689 1.187e-18 8.002e-17
70 POSITIVE REGULATION OF NEURON DIFFERENTIATION 81 306 1.282e-18 8.402e-17
71 SENSORY ORGAN DEVELOPMENT 110 493 1.281e-18 8.402e-17
72 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 86 337 1.349e-18 8.72e-17
73 EMBRYO DEVELOPMENT 165 894 1.988e-18 1.267e-16
74 REGULATION OF EPITHELIAL CELL PROLIFERATION 77 285 2.548e-18 1.602e-16
75 NEGATIVE REGULATION OF CELL DIFFERENTIATION 126 609 2.689e-18 1.668e-16
76 UROGENITAL SYSTEM DEVELOPMENT 79 299 3.867e-18 2.368e-16
77 MESENCHYME DEVELOPMENT 60 190 4.465e-18 2.698e-16
78 RESPONSE TO EXTERNAL STIMULUS 277 1821 7.572e-18 4.517e-16
79 MUSCLE STRUCTURE DEVELOPMENT 99 432 1.052e-17 6.193e-16
80 REGULATION OF RESPONSE TO WOUNDING 96 413 1.221e-17 7.1e-16
81 HEAD DEVELOPMENT 138 709 1.532e-17 8.799e-16
82 RESPONSE TO GROWTH FACTOR 105 475 1.605e-17 9.107e-16
83 NEURON PROJECTION MORPHOGENESIS 94 402 1.775e-17 9.949e-16
84 STEM CELL DIFFERENTIATION 59 190 2.068e-17 1.145e-15
85 EMBRYONIC MORPHOGENESIS 114 539 2.132e-17 1.167e-15
86 POSITIVE REGULATION OF CELL PROLIFERATION 151 814 3.889e-17 2.104e-15
87 REGULATION OF GROWTH 126 633 6.788e-17 3.631e-15
88 BEHAVIOR 109 516 1.209e-16 6.39e-15
89 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 164 926 1.433e-16 7.494e-15
90 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 65 232 1.591e-16 8.227e-15
91 INTRACELLULAR SIGNAL TRANSDUCTION 243 1572 1.666e-16 8.518e-15
92 POSITIVE REGULATION OF MAPK CASCADE 102 470 1.768e-16 8.941e-15
93 POSITIVE REGULATION OF MOLECULAR FUNCTION 268 1791 2.461e-16 1.231e-14
94 SINGLE ORGANISM CELL ADHESION 100 459 2.684e-16 1.329e-14
95 REGULATION OF DEVELOPMENTAL GROWTH 74 289 2.871e-16 1.406e-14
96 CELL PROJECTION ORGANIZATION 160 902 2.998e-16 1.453e-14
97 REGULATION OF MAPK CASCADE 128 660 3.244e-16 1.556e-14
98 REGULATION OF PROTEIN MODIFICATION PROCESS 258 1710 3.561e-16 1.691e-14
99 CELL ACTIVATION 115 568 4.513e-16 2.121e-14
100 MESENCHYMAL CELL DIFFERENTIATION 46 134 9.923e-16 4.617e-14
101 MORPHOGENESIS OF AN EPITHELIUM 90 400 1.095e-15 5.043e-14
102 RESPONSE TO HORMONE 157 893 1.31e-15 5.935e-14
103 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 75 303 1.314e-15 5.935e-14
104 RESPONSE TO ORGANIC CYCLIC COMPOUND 160 917 1.377e-15 6.102e-14
105 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 85 368 1.368e-15 6.102e-14
106 REGULATION OF ION TRANSPORT 117 592 1.57e-15 6.892e-14
107 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 49 153 2.733e-15 1.188e-13
108 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 49 154 3.653e-15 1.574e-13
109 SINGLE ORGANISM BEHAVIOR 86 384 6.368e-15 2.718e-13
110 RESPONSE TO LIPID 154 888 8.346e-15 3.53e-13
111 SYNAPSE ASSEMBLY 31 69 8.847e-15 3.709e-13
112 WOUND HEALING 98 470 1.041e-14 4.324e-13
113 REGULATION OF BLOOD CIRCULATION 72 295 1.064e-14 4.381e-13
114 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 152 876 1.206e-14 4.924e-13
115 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 186 1152 1.486e-14 6.011e-13
116 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 225 1492 3.977e-14 1.595e-12
117 POSITIVE REGULATION OF CATALYTIC ACTIVITY 228 1518 4.063e-14 1.616e-12
118 GROWTH 88 410 4.285e-14 1.69e-12
119 LEUKOCYTE MIGRATION 65 259 5.204e-14 2.035e-12
120 EMBRYONIC ORGAN DEVELOPMENT 87 406 6.605e-14 2.561e-12
121 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 44 138 8.502e-14 3.27e-12
122 REGULATION OF EPITHELIAL CELL MIGRATION 49 166 9.522e-14 3.632e-12
123 REGULATION OF ANATOMICAL STRUCTURE SIZE 96 472 9.667e-14 3.657e-12
124 RESPONSE TO NITROGEN COMPOUND 147 859 1.068e-13 4.008e-12
125 IMMUNE SYSTEM PROCESS 279 1984 1.459e-13 5.432e-12
126 REGULATION OF AXONOGENESIS 49 168 1.58e-13 5.836e-12
127 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 55 204 1.954e-13 7.159e-12
128 REGULATION OF ACTIN FILAMENT BASED PROCESS 72 312 2.178e-13 7.916e-12
129 NEGATIVE REGULATION OF LOCOMOTION 64 263 3.722e-13 1.343e-11
130 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 69 296 4.137e-13 1.481e-11
131 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 179 1135 4.257e-13 1.512e-11
132 TUBE MORPHOGENESIS 73 323 4.482e-13 1.58e-11
133 MUSCLE ORGAN DEVELOPMENT 66 277 4.571e-13 1.599e-11
134 REGULATION OF VASCULATURE DEVELOPMENT 59 233 5.04e-13 1.75e-11
135 MORPHOGENESIS OF A BRANCHING STRUCTURE 48 167 5.097e-13 1.757e-11
136 REGULATION OF CELL DEATH 218 1472 6.773e-13 2.317e-11
137 REGULATION OF CHEMOTAXIS 50 180 7.06e-13 2.398e-11
138 EYE DEVELOPMENT 73 326 7.277e-13 2.454e-11
139 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 58 229 7.853e-13 2.629e-11
140 ARTERY DEVELOPMENT 30 75 1.001e-12 3.327e-11
141 CONNECTIVE TISSUE DEVELOPMENT 52 194 1.133e-12 3.739e-11
142 REGULATION OF MEMBRANE POTENTIAL 75 343 1.248e-12 4.09e-11
143 CELLULAR RESPONSE TO HORMONE STIMULUS 104 552 1.417e-12 4.61e-11
144 PROTEIN PHOSPHORYLATION 154 944 1.444e-12 4.665e-11
145 CELL PART MORPHOGENESIS 114 633 2.534e-12 8.131e-11
146 CELLULAR RESPONSE TO NITROGEN COMPOUND 97 505 2.557e-12 8.149e-11
147 RESPONSE TO ALCOHOL 77 362 2.73e-12 8.642e-11
148 POSITIVE REGULATION OF CELL ADHESION 79 376 2.755e-12 8.661e-11
149 NEGATIVE REGULATION OF CELL ADHESION 56 223 2.827e-12 8.83e-11
150 REGULATION OF CELL GROWTH 81 391 3.149e-12 9.769e-11
151 REGULATION OF SYNAPSE ORGANIZATION 37 113 3.215e-12 9.907e-11
152 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 34 98 3.813e-12 1.167e-10
153 LEUKOCYTE ACTIVATION 84 414 3.972e-12 1.208e-10
154 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 57 232 4.739e-12 1.432e-10
155 AMEBOIDAL TYPE CELL MIGRATION 44 154 5.9e-12 1.771e-10
156 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 95 498 6.493e-12 1.937e-10
157 REGULATION OF KINASE ACTIVITY 131 776 6.762e-12 2.004e-10
158 IMMUNE SYSTEM DEVELOPMENT 106 582 7.527e-12 2.217e-10
159 RESPIRATORY SYSTEM DEVELOPMENT 51 197 7.773e-12 2.275e-10
160 REGULATION OF HYDROLASE ACTIVITY 197 1327 8.061e-12 2.344e-10
161 REGULATION OF CELL SUBSTRATE ADHESION 47 173 8.157e-12 2.348e-10
162 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 63 274 8.177e-12 2.348e-10
163 MUSCLE TISSUE DEVELOPMENT 63 275 9.666e-12 2.759e-10
164 POSITIVE REGULATION OF TRANSPORT 150 936 1.154e-11 3.275e-10
165 HEART MORPHOGENESIS 53 212 1.299e-11 3.663e-10
166 RESPONSE TO OXYGEN LEVELS 68 311 1.407e-11 3.945e-10
167 NEGATIVE REGULATION OF CELL PROLIFERATION 113 643 1.578e-11 4.396e-10
168 DEVELOPMENTAL GROWTH 71 333 1.728e-11 4.786e-10
169 CARTILAGE DEVELOPMENT 42 147 1.777e-11 4.891e-10
170 EMBRYONIC ORGAN MORPHOGENESIS 63 279 1.868e-11 5.093e-10
171 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 34 103 1.872e-11 5.093e-10
172 REGULATION OF IMMUNE SYSTEM PROCESS 204 1403 2.271e-11 6.144e-10
173 LYMPHOCYTE ACTIVATION 72 342 2.323e-11 6.249e-10
174 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 34 104 2.535e-11 6.78e-10
175 FOREBRAIN DEVELOPMENT 74 357 2.664e-11 7.084e-10
176 MUSCLE SYSTEM PROCESS 63 282 3.028e-11 8.005e-10
177 CARDIAC CHAMBER DEVELOPMENT 41 144 3.479e-11 9.146e-10
178 NEURON PROJECTION GUIDANCE 51 205 3.823e-11 9.992e-10
179 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 39 133 3.901e-11 1.014e-09
180 SYSTEM PROCESS 246 1785 4.281e-11 1.107e-09
181 REGULATION OF TRANSMEMBRANE TRANSPORT 83 426 4.708e-11 1.21e-09
182 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 100 554 5.081e-11 1.299e-09
183 POSITIVE REGULATION OF HYDROLASE ACTIVITY 144 905 5.173e-11 1.315e-09
184 SENSORY ORGAN MORPHOGENESIS 56 239 5.394e-11 1.364e-09
185 EPITHELIAL CELL DIFFERENTIATION 92 495 6.121e-11 1.539e-09
186 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 25 62 6.287e-11 1.573e-09
187 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 26 67 7.277e-11 1.811e-09
188 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 50 203 8.72e-11 2.158e-09
189 REGULATION OF BODY FLUID LEVELS 93 506 8.992e-11 2.211e-09
190 REGULATION OF ORGAN MORPHOGENESIS 56 242 9.027e-11 2.211e-09
191 SECOND MESSENGER MEDIATED SIGNALING 43 160 9.154e-11 2.218e-09
192 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 59 262 9.125e-11 2.218e-09
193 NEGATIVE REGULATION OF CELL DEVELOPMENT 65 303 9.391e-11 2.264e-09
194 REGULATION OF ENDOTHELIAL CELL MIGRATION 35 114 9.47e-11 2.271e-09
195 POSITIVE REGULATION OF CHEMOTAXIS 36 120 1.068e-10 2.547e-09
196 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 26 68 1.075e-10 2.552e-09
197 REGULATION OF GTPASE ACTIVITY 114 673 1.339e-10 3.163e-09
198 COLLAGEN FIBRIL ORGANIZATION 19 38 1.351e-10 3.174e-09
199 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 43 162 1.413e-10 3.303e-09
200 LEUKOCYTE DIFFERENTIATION 63 292 1.42e-10 3.304e-09
201 REGULATION OF SECRETION 117 699 1.622e-10 3.755e-09
202 CELLULAR RESPONSE TO ACID CHEMICAL 45 175 1.662e-10 3.81e-09
203 REGULATION OF CELLULAR LOCALIZATION 186 1277 1.658e-10 3.81e-09
204 ARTERY MORPHOGENESIS 22 51 1.826e-10 4.166e-09
205 REGULATION OF INFLAMMATORY RESPONSE 63 294 1.912e-10 4.341e-09
206 REGULATION OF CELL ACTIVATION 89 484 2.235e-10 5.049e-09
207 NEURAL CREST CELL DIFFERENTIATION 27 75 2.365e-10 5.316e-09
208 NEGATIVE CHEMOTAXIS 19 39 2.405e-10 5.38e-09
209 SECRETION 102 588 3.347e-10 7.452e-09
210 DIGESTIVE SYSTEM DEVELOPMENT 40 148 3.414e-10 7.564e-09
211 MUSCLE CELL DIFFERENTIATION 54 237 3.588e-10 7.912e-09
212 NEGATIVE REGULATION OF CELL DEATH 137 872 3.75e-10 8.23e-09
213 COGNITION 56 251 3.963e-10 8.616e-09
214 OSSIFICATION 56 251 3.963e-10 8.616e-09
215 CELL CHEMOTAXIS 42 162 5.099e-10 1.098e-08
216 POSITIVE REGULATION OF RESPONSE TO WOUNDING 42 162 5.099e-10 1.098e-08
217 BONE DEVELOPMENT 41 156 5.222e-10 1.115e-08
218 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 41 156 5.222e-10 1.115e-08
219 REGULATION OF BLOOD PRESSURE 43 169 6.028e-10 1.281e-08
220 VASCULAR PROCESS IN CIRCULATORY SYSTEM 42 163 6.262e-10 1.324e-08
221 SPROUTING ANGIOGENESIS 20 45 6.412e-10 1.35e-08
222 REGULATION OF HEART CONTRACTION 51 221 6.852e-10 1.436e-08
223 REGULATION OF WNT SIGNALING PATHWAY 64 310 6.935e-10 1.441e-08
224 EAR DEVELOPMENT 47 195 6.914e-10 1.441e-08
225 REGULATION OF METAL ION TRANSPORT 66 325 7.746e-10 1.602e-08
226 REGULATION OF CALCIUM ION TRANSPORT 49 209 8.32e-10 1.705e-08
227 LYMPHOCYTE DIFFERENTIATION 49 209 8.32e-10 1.705e-08
228 POSITIVE REGULATION OF OSSIFICATION 28 84 8.593e-10 1.754e-08
229 RESPONSE TO ACID CHEMICAL 65 319 9.003e-10 1.829e-08
230 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 135 867 9.231e-10 1.868e-08
231 POSITIVE REGULATION OF KINASE ACTIVITY 87 482 9.316e-10 1.877e-08
232 POSITIVE REGULATION OF GENE EXPRESSION 234 1733 9.524e-10 1.91e-08
233 REGULATION OF OSSIFICATION 44 178 1.027e-09 2.051e-08
234 SYNAPTIC SIGNALING 79 424 1.237e-09 2.459e-08
235 REGULATION OF CYTOKINE PRODUCTION 97 563 1.325e-09 2.623e-08
236 GLAND DEVELOPMENT 75 395 1.362e-09 2.685e-08
237 MODULATION OF SYNAPTIC TRANSMISSION 62 301 1.404e-09 2.757e-08
238 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 48 207 1.822e-09 3.563e-08
239 REGULATION OF WOUND HEALING 35 126 1.93e-09 3.758e-08
240 RESPONSE TO STEROID HORMONE 88 497 1.992e-09 3.862e-08
241 REGULATION OF MUSCLE SYSTEM PROCESS 46 195 2.2e-09 4.247e-08
242 NEPHRON DEVELOPMENT 33 115 2.247e-09 4.32e-08
243 POSITIVE REGULATION OF CYTOKINE PRODUCTION 71 370 2.343e-09 4.487e-08
244 RESPONSE TO ABIOTIC STIMULUS 152 1024 2.414e-09 4.604e-08
245 CARDIAC CHAMBER MORPHOGENESIS 31 104 2.472e-09 4.695e-08
246 REPRODUCTIVE SYSTEM DEVELOPMENT 76 408 2.578e-09 4.877e-08
247 NEURON MIGRATION 32 110 2.693e-09 5.073e-08
248 NEGATIVE REGULATION OF CELL ACTIVATION 40 158 2.776e-09 5.208e-08
249 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 58 278 2.877e-09 5.376e-08
250 SECRETION BY CELL 86 486 3.135e-09 5.834e-08
251 REGULATION OF CELLULAR COMPONENT BIOGENESIS 121 767 3.249e-09 6.023e-08
252 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 45 191 3.418e-09 6.311e-08
253 NEGATIVE REGULATION OF WOUND HEALING 22 58 3.473e-09 6.387e-08
254 REGULATION OF CELL SIZE 42 172 3.63e-09 6.649e-08
255 CELLULAR RESPONSE TO LIPID 82 457 3.77e-09 6.879e-08
256 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 41 166 3.877e-09 7.047e-08
257 CARDIAC VENTRICLE DEVELOPMENT 31 106 4.124e-09 7.466e-08
258 DENDRITE DEVELOPMENT 26 79 4.647e-09 8.348e-08
259 REGULATION OF SYNAPSE ASSEMBLY 26 79 4.647e-09 8.348e-08
260 REGULATION OF EXTENT OF CELL GROWTH 30 101 4.881e-09 8.736e-08
261 MULTI MULTICELLULAR ORGANISM PROCESS 48 213 4.939e-09 8.806e-08
262 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 238 1805 5.921e-09 1.052e-07
263 SKELETAL SYSTEM MORPHOGENESIS 46 201 6.139e-09 1.086e-07
264 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 30 102 6.308e-09 1.112e-07
265 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 39 156 6.4e-09 1.124e-07
266 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 92 541 6.889e-09 1.201e-07
267 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 92 541 6.889e-09 1.201e-07
268 REGULATION OF CELL CELL ADHESION 71 380 7.531e-09 1.308e-07
269 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 33 121 9.166e-09 1.586e-07
270 NEGATIVE REGULATION OF TRANSPORT 81 458 9.242e-09 1.593e-07
271 DENDRITE MORPHOGENESIS 18 42 9.401e-09 1.614e-07
272 CARDIAC MUSCLE TISSUE DEVELOPMENT 36 140 1.091e-08 1.866e-07
273 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 33 122 1.146e-08 1.953e-07
274 REGULATION OF MESENCHYMAL CELL PROLIFERATION 16 34 1.207e-08 2.049e-07
275 REGULATION OF MUSCLE CONTRACTION 37 147 1.277e-08 2.16e-07
276 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 35 135 1.383e-08 2.323e-07
277 CELL GROWTH 35 135 1.383e-08 2.323e-07
278 REGULATION OF HOMEOSTATIC PROCESS 79 447 1.453e-08 2.431e-07
279 LEUKOCYTE CELL CELL ADHESION 53 255 1.568e-08 2.616e-07
280 CELL PROLIFERATION 107 672 1.641e-08 2.727e-07
281 TELENCEPHALON DEVELOPMENT 49 228 1.767e-08 2.925e-07
282 DIVALENT INORGANIC CATION HOMEOSTASIS 65 343 1.832e-08 3.023e-07
283 NEGATIVE REGULATION OF GROWTH 50 236 2.072e-08 3.406e-07
284 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 34 131 2.152e-08 3.526e-07
285 ENDOTHELIUM DEVELOPMENT 27 90 2.239e-08 3.656e-07
286 ACTIVATION OF PROTEIN KINASE ACTIVITY 56 279 2.26e-08 3.677e-07
287 GLOMERULUS DEVELOPMENT 19 49 2.655e-08 4.304e-07
288 REGULATED EXOCYTOSIS 48 224 2.713e-08 4.374e-07
289 POSITIVE REGULATION OF AXONOGENESIS 23 69 2.717e-08 4.374e-07
290 CELL SUBSTRATE ADHESION 39 164 2.836e-08 4.551e-07
291 VASCULOGENESIS 21 59 2.934e-08 4.691e-07
292 NEGATIVE REGULATION OF PLATELET ACTIVATION 11 17 3.066e-08 4.885e-07
293 REGULATION OF CELL SHAPE 35 139 3.097e-08 4.919e-07
294 REGULATION OF MUSCLE TISSUE DEVELOPMENT 29 103 3.309e-08 5.219e-07
295 REGULATION OF MUSCLE ORGAN DEVELOPMENT 29 103 3.309e-08 5.219e-07
296 REGULATION OF MAP KINASE ACTIVITY 61 319 3.547e-08 5.576e-07
297 MUSCLE CONTRACTION 49 233 3.663e-08 5.738e-07
298 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 80 465 3.972e-08 6.202e-07
299 REGULATION OF SMOOTH MUSCLE CONTRACTION 21 60 4.121e-08 6.392e-07
300 CRANIAL SKELETAL SYSTEM DEVELOPMENT 20 55 4.118e-08 6.392e-07
301 STRIATED MUSCLE CELL DIFFERENTIATION 40 173 4.356e-08 6.734e-07
302 AORTA DEVELOPMENT 17 41 4.415e-08 6.803e-07
303 REGULATION OF CELLULAR COMPONENT SIZE 63 337 5.115e-08 7.854e-07
304 REGULATION OF ION HOMEOSTASIS 44 201 5.282e-08 8.085e-07
305 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 49 236 5.595e-08 8.536e-07
306 NEURAL CREST CELL MIGRATION 19 51 5.694e-08 8.658e-07
307 REGULATION OF COAGULATION 26 88 5.74e-08 8.671e-07
308 REGULATION OF STEM CELL PROLIFERATION 26 88 5.74e-08 8.671e-07
309 REGULATION OF RESPONSE TO STRESS 196 1468 6.114e-08 9.206e-07
310 ACTION POTENTIAL 27 94 6.176e-08 9.27e-07
311 INFLAMMATORY RESPONSE 78 454 6.224e-08 9.312e-07
312 EAR MORPHOGENESIS 30 112 6.657e-08 9.928e-07
313 AUTONOMIC NERVOUS SYSTEM DEVELOPMENT 17 42 6.778e-08 1.008e-06
314 PHOSPHORYLATION 169 1228 7.233e-08 1.072e-06
315 POSITIVE REGULATION OF GROWTH 49 238 7.38e-08 1.087e-06
316 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 230 1784 7.367e-08 1.087e-06
317 LEARNING 33 131 7.518e-08 1.103e-06
318 CARDIAC VENTRICLE MORPHOGENESIS 21 62 7.924e-08 1.159e-06
319 NEGATIVE REGULATION OF CELL GROWTH 39 170 7.997e-08 1.166e-06
320 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 35 144 8.044e-08 1.17e-06
321 PATTERN SPECIFICATION PROCESS 73 418 8.392e-08 1.216e-06
322 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 16 38 8.499e-08 1.228e-06
323 REGULATION OF ORGAN GROWTH 23 73 8.916e-08 1.284e-06
324 ACTIN FILAMENT BASED PROCESS 77 450 8.983e-08 1.29e-06
325 NEGATIVE REGULATION OF NEURON DEATH 39 171 9.447e-08 1.352e-06
326 CALCIUM MEDIATED SIGNALING 26 90 9.496e-08 1.355e-06
327 CYTOKINE PRODUCTION 31 120 9.981e-08 1.418e-06
328 CARDIOCYTE DIFFERENTIATION 27 96 9.995e-08 1.418e-06
329 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 143 1004 1.011e-07 1.43e-06
330 WNT SIGNALING PATHWAY 64 351 1.049e-07 1.479e-06
331 REGULATION OF NEURON APOPTOTIC PROCESS 42 192 1.075e-07 1.512e-06
332 REGULATION OF CARTILAGE DEVELOPMENT 21 63 1.085e-07 1.521e-06
333 CARDIAC SEPTUM DEVELOPMENT 25 85 1.134e-07 1.57e-06
334 NEGATIVE REGULATION OF COAGULATION 18 48 1.13e-07 1.57e-06
335 PALATE DEVELOPMENT 25 85 1.134e-07 1.57e-06
336 DIGESTIVE TRACT MORPHOGENESIS 18 48 1.13e-07 1.57e-06
337 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 19 53 1.167e-07 1.611e-06
338 PEPTIDYL TYROSINE MODIFICATION 41 186 1.217e-07 1.675e-06
339 REGULATION OF TRANSFERASE ACTIVITY 136 946 1.221e-07 1.675e-06
340 GLAND MORPHOGENESIS 27 97 1.264e-07 1.73e-06
341 REGULATION OF PHOSPHOLIPASE ACTIVITY 21 64 1.475e-07 2.013e-06
342 INNER EAR MORPHOGENESIS 26 92 1.543e-07 2.1e-06
343 FORMATION OF PRIMARY GERM LAYER 29 110 1.593e-07 2.161e-06
344 CELLULAR CHEMICAL HOMEOSTASIS 91 570 1.73e-07 2.34e-06
345 CHEMICAL HOMEOSTASIS 127 874 1.787e-07 2.41e-06
346 T CELL DIFFERENTIATION 31 123 1.826e-07 2.455e-06
347 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 66 372 1.912e-07 2.563e-06
348 RESPONSE TO MECHANICAL STIMULUS 44 210 1.999e-07 2.673e-06
349 APPENDAGE DEVELOPMENT 38 169 2.029e-07 2.698e-06
350 LIMB DEVELOPMENT 38 169 2.029e-07 2.698e-06
351 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 13 27 2.056e-07 2.725e-06
352 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 10 16 2.161e-07 2.857e-06
353 INOSITOL LIPID MEDIATED SIGNALING 31 124 2.221e-07 2.927e-06
354 REGULATION OF PROTEIN SECRETION 68 389 2.229e-07 2.929e-06
355 REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 18 50 2.329e-07 3.045e-06
356 RHYTHMIC PROCESS 56 298 2.329e-07 3.045e-06
357 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 70 406 2.554e-07 3.329e-06
358 DEVELOPMENTAL CELL GROWTH 23 77 2.65e-07 3.444e-06
359 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 78 470 2.707e-07 3.509e-06
360 OVULATION CYCLE 29 113 2.973e-07 3.811e-06
361 CELL FATE COMMITMENT 46 227 2.972e-07 3.811e-06
362 POSITIVE REGULATION OF STEM CELL PROLIFERATION 20 61 2.951e-07 3.811e-06
363 POSITIVE REGULATION OF INFLAMMATORY RESPONSE 29 113 2.973e-07 3.811e-06
364 ENDOTHELIAL CELL DIFFERENTIATION 22 72 3.092e-07 3.953e-06
365 OUTFLOW TRACT MORPHOGENESIS 19 56 3.174e-07 4.046e-06
366 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 17 46 3.248e-07 4.13e-06
367 REGULATION OF POSITIVE CHEMOTAXIS 12 24 3.618e-07 4.587e-06
368 REGULATION OF EMBRYONIC DEVELOPMENT 29 114 3.638e-07 4.6e-06
369 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 24 84 3.674e-07 4.62e-06
370 TISSUE MIGRATION 24 84 3.674e-07 4.62e-06
371 REGULATION OF CELL MATRIX ADHESION 25 90 3.821e-07 4.792e-06
372 HEMOSTASIS 57 311 4.316e-07 5.398e-06
373 CYCLIC NUCLEOTIDE METABOLIC PROCESS 19 57 4.349e-07 5.425e-06
374 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 23 79 4.419e-07 5.483e-06
375 BONE MORPHOGENESIS 23 79 4.419e-07 5.483e-06
376 REGULATION OF HEART GROWTH 16 42 4.443e-07 5.499e-06
377 CALCIUM ION TRANSPORT 45 223 4.509e-07 5.551e-06
378 REGULATION OF PROTEIN LOCALIZATION 134 950 4.506e-07 5.551e-06
379 NERVE DEVELOPMENT 21 68 4.684e-07 5.751e-06
380 MUSCLE CELL DEVELOPMENT 31 128 4.736e-07 5.799e-06
381 NEURON RECOGNITION 14 33 4.914e-07 6.002e-06
382 RESPONSE TO KETONE 39 182 5.298e-07 6.453e-06
383 ION HOMEOSTASIS 90 576 5.319e-07 6.461e-06
384 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 29 116 5.4e-07 6.544e-06
385 NEGATIVE REGULATION OF PHOSPHORYLATION 71 422 5.46e-07 6.599e-06
386 PLATELET ACTIVATION 33 142 5.679e-07 6.845e-06
387 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 29 117 6.551e-07 7.877e-06
388 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 109 740 6.976e-07 8.366e-06
389 LIPID PHOSPHORYLATION 26 99 7.438e-07 8.896e-06
390 MULTICELLULAR ORGANISM METABOLIC PROCESS 25 93 7.524e-07 8.954e-06
391 POSITIVE REGULATION OF BLOOD CIRCULATION 25 93 7.524e-07 8.954e-06
392 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 33 144 7.969e-07 9.459e-06
393 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 21 70 8.024e-07 9.5e-06
394 COCHLEA DEVELOPMENT 15 39 8.807e-07 1.04e-05
395 KIDNEY EPITHELIUM DEVELOPMENT 30 125 8.861e-07 1.044e-05
396 RESPONSE TO PEPTIDE 68 404 9.283e-07 1.084e-05
397 POSITIVE REGULATION OF MAP KINASE ACTIVITY 42 207 9.258e-07 1.084e-05
398 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 68 404 9.283e-07 1.084e-05
399 CELLULAR HOMEOSTASIS 101 676 9.296e-07 1.084e-05
400 LEUKOCYTE PROLIFERATION 24 88 9.365e-07 1.089e-05
401 AMINOGLYCAN METABOLIC PROCESS 36 166 1.058e-06 1.225e-05
402 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 42 208 1.058e-06 1.225e-05
403 OSTEOBLAST DIFFERENTIATION 30 126 1.061e-06 1.225e-05
404 AMINOGLYCAN BIOSYNTHETIC PROCESS 27 107 1.08e-06 1.241e-05
405 PLATELET DEGRANULATION 27 107 1.08e-06 1.241e-05
406 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 12 26 1.083e-06 1.241e-05
407 REGULATION OF NEURON DEATH 48 252 1.109e-06 1.268e-05
408 PROTEOGLYCAN METABOLIC PROCESS 23 83 1.157e-06 1.32e-05
409 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 18 55 1.184e-06 1.347e-05
410 LOCOMOTORY BEHAVIOR 38 181 1.257e-06 1.427e-05
411 DIVALENT INORGANIC CATION TRANSPORT 50 268 1.264e-06 1.431e-05
412 MEMBRANE DEPOLARIZATION 19 61 1.413e-06 1.592e-05
413 POSITIVE REGULATION OF SYNAPSE ASSEMBLY 19 61 1.413e-06 1.592e-05
414 REGULATION OF HOMOTYPIC CELL CELL ADHESION 55 307 1.432e-06 1.609e-05
415 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 9 15 1.472e-06 1.651e-05
416 REGULATION OF PLATELET ACTIVATION 13 31 1.483e-06 1.659e-05
417 EPITHELIAL TO MESENCHYMAL TRANSITION 18 56 1.595e-06 1.78e-05
418 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 40 197 1.634e-06 1.806e-05
419 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 31 135 1.624e-06 1.806e-05
420 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 35 162 1.629e-06 1.806e-05
421 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 40 197 1.634e-06 1.806e-05
422 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 39 190 1.656e-06 1.826e-05
423 RESPONSE TO CORTICOSTEROID 37 176 1.668e-06 1.831e-05
424 REGULATION OF IMMUNE RESPONSE 121 858 1.668e-06 1.831e-05
425 POSITIVE CHEMOTAXIS 14 36 1.744e-06 1.91e-05
426 POSITIVE REGULATION OF HEART GROWTH 12 27 1.785e-06 1.95e-05
427 EYE MORPHOGENESIS 31 136 1.919e-06 2.091e-05
428 EXOCYTOSIS 55 310 1.953e-06 2.123e-05
429 MULTICELLULAR ORGANISMAL SIGNALING 29 123 1.974e-06 2.141e-05
430 ENDOTHELIAL CELL MIGRATION 18 57 2.13e-06 2.302e-05
431 REGULATION OF ENDOCYTOSIS 40 199 2.132e-06 2.302e-05
432 LEUKOCYTE CHEMOTAXIS 28 117 2.152e-06 2.318e-05
433 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 21 74 2.194e-06 2.352e-05
434 CARDIAC MUSCLE CELL DIFFERENTIATION 21 74 2.194e-06 2.352e-05
435 CELL JUNCTION ORGANIZATION 38 185 2.2e-06 2.353e-05
436 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 22 80 2.261e-06 2.413e-05
437 POSITIVE REGULATION OF ION TRANSPORT 45 236 2.302e-06 2.452e-05
438 NEGATIVE REGULATION OF SECRETION 40 200 2.43e-06 2.582e-05
439 CORONARY VASCULATURE DEVELOPMENT 14 37 2.568e-06 2.715e-05
440 AXON EXTENSION 14 37 2.568e-06 2.715e-05
441 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 24 93 2.747e-06 2.898e-05
442 REGULATION OF OSTEOBLAST DIFFERENTIATION 27 112 2.798e-06 2.946e-05
443 PROTEOGLYCAN BIOSYNTHETIC PROCESS 18 58 2.823e-06 2.965e-05
444 METANEPHROS DEVELOPMENT 22 81 2.835e-06 2.971e-05
445 METAL ION TRANSPORT 88 582 2.848e-06 2.975e-05
446 HOMEOSTATIC PROCESS 173 1337 2.858e-06 2.975e-05
447 REGULATION OF MUSCLE CELL DIFFERENTIATION 33 152 2.856e-06 2.975e-05
448 REGULATION OF ERK1 AND ERK2 CASCADE 45 238 2.914e-06 3.026e-05
449 NEURON CELL CELL ADHESION 9 16 3.088e-06 3.2e-05
450 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 17 53 3.197e-06 3.291e-05
451 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 17 53 3.197e-06 3.291e-05
452 NEURON PROJECTION EXTENSION 17 53 3.197e-06 3.291e-05
453 MUSCLE ORGAN MORPHOGENESIS 20 70 3.393e-06 3.485e-05
454 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 90 602 3.533e-06 3.621e-05
455 REGULATION OF SEQUESTERING OF CALCIUM ION 26 107 3.632e-06 3.714e-05
456 REGULATION OF RENAL SYSTEM PROCESS 14 38 3.72e-06 3.795e-05
457 RESPONSE TO ESTROGEN 42 218 3.761e-06 3.829e-05
458 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 70 437 3.992e-06 4.056e-05
459 POSITIVE REGULATION OF ENDOCYTOSIS 27 114 4.014e-06 4.069e-05
460 ION TRANSPORT 164 1262 4.093e-06 4.14e-05
461 VENTRICULAR SEPTUM DEVELOPMENT 17 54 4.266e-06 4.306e-05
462 MUCOPOLYSACCHARIDE METABOLIC PROCESS 26 108 4.366e-06 4.398e-05
463 REGULATION OF PROTEIN IMPORT 37 183 4.387e-06 4.408e-05
464 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 21 77 4.412e-06 4.425e-05
465 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 12 29 4.469e-06 4.471e-05
466 RESPONSE TO DRUG 69 431 4.762e-06 4.754e-05
467 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 16 49 4.773e-06 4.755e-05
468 CHONDROCYTE DIFFERENTIATION 18 60 4.847e-06 4.809e-05
469 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 18 60 4.847e-06 4.809e-05
470 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 37 184 5.008e-06 4.958e-05
471 REGULATION OF CYTOKINE SECRETION 32 149 5.113e-06 5.043e-05
472 CAMP METABOLIC PROCESS 13 34 5.116e-06 5.043e-05
473 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 91 616 5.128e-06 5.044e-05
474 POSITIVE REGULATION OF CELL CELL ADHESION 45 243 5.162e-06 5.067e-05
475 MESODERM MORPHOGENESIS 19 66 5.242e-06 5.125e-05
476 REGULATION OF VASOCONSTRICTION 19 66 5.242e-06 5.125e-05
477 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 14 39 5.309e-06 5.168e-05
478 REGULATION OF AXON GUIDANCE 14 39 5.309e-06 5.168e-05
479 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 22 84 5.441e-06 5.285e-05
480 CELLULAR RESPONSE TO PEPTIDE 49 274 5.535e-06 5.366e-05
481 CELLULAR RESPONSE TO OXYGEN LEVELS 31 143 5.829e-06 5.639e-05
482 CHONDROCYTE DEVELOPMENT 10 21 6.162e-06 5.949e-05
483 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 26 110 6.258e-06 6.028e-05
484 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 16 50 6.418e-06 6.17e-05
485 REGULATION OF DEFENSE RESPONSE 107 759 6.789e-06 6.499e-05
486 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 35 172 6.782e-06 6.499e-05
487 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 12 30 6.821e-06 6.517e-05
488 REGULATION OF CYTOSKELETON ORGANIZATION 77 502 6.953e-06 6.629e-05
489 SMOOTH MUSCLE CONTRACTION 15 45 7.073e-06 6.73e-05
490 IMMUNE RESPONSE 145 1100 7.153e-06 6.793e-05
491 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 17 56 7.41e-06 7.022e-05
492 POSITIVE REGULATION OF CELL DEATH 89 605 7.692e-06 7.274e-05
493 REGULATION OF JNK CASCADE 33 159 7.935e-06 7.489e-05
494 MESODERM DEVELOPMENT 27 118 8.001e-06 7.536e-05
495 B CELL ACTIVATION 29 132 8.76e-06 8.235e-05
496 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 24 99 8.859e-06 8.27e-05
497 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 24 99 8.859e-06 8.27e-05
498 RESPONSE TO AMINO ACID 26 112 8.869e-06 8.27e-05
499 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 24 99 8.859e-06 8.27e-05
500 PALLIUM DEVELOPMENT 32 153 9.156e-06 8.521e-05
501 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 40 211 9.49e-06 8.814e-05
502 REGULATION OF CHONDROCYTE DIFFERENTIATION 15 46 9.601e-06 8.899e-05
503 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 8 14 9.637e-06 8.913e-05
504 REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 17 57 9.654e-06 8.913e-05
505 IN UTERO EMBRYONIC DEVELOPMENT 53 311 9.939e-06 9.139e-05
506 POSITIVE REGULATION OF CELL ACTIVATION 53 311 9.939e-06 9.139e-05
507 LUNG ALVEOLUS DEVELOPMENT 14 41 1.039e-05 9.532e-05
508 REGULATION OF SYNAPTIC PLASTICITY 30 140 1.044e-05 9.558e-05
509 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 24 100 1.064e-05 9.73e-05
510 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 20 75 1.072e-05 9.776e-05
511 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 9 18 1.105e-05 1e-04
512 REGULATION OF COLLATERAL SPROUTING 9 18 1.105e-05 1e-04
513 RETINAL GANGLION CELL AXON GUIDANCE 9 18 1.105e-05 1e-04
514 PHARYNGEAL SYSTEM DEVELOPMENT 9 18 1.105e-05 1e-04
515 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 50 289 1.15e-05 0.0001035
516 RESPONSE TO BMP 23 94 1.149e-05 0.0001035
517 CELLULAR RESPONSE TO BMP STIMULUS 23 94 1.149e-05 0.0001035
518 REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY 28 127 1.159e-05 0.0001041
519 GASTRULATION 32 155 1.213e-05 0.0001087
520 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 237 1977 1.243e-05 0.0001112
521 KIDNEY MORPHOGENESIS 21 82 1.287e-05 0.0001148
522 INTEGRIN MEDIATED SIGNALING PATHWAY 21 82 1.287e-05 0.0001148
523 REGULATION OF CALCIUM MEDIATED SIGNALING 20 76 1.329e-05 0.0001182
524 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 11 27 1.345e-05 0.0001194
525 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 26 115 1.467e-05 0.00013
526 CYTOSOLIC CALCIUM ION TRANSPORT 16 53 1.48e-05 0.0001309
527 REGULATION OF LIPASE ACTIVITY 21 83 1.575e-05 0.000139
528 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 25 109 1.637e-05 0.0001442
529 INNERVATION 10 23 1.68e-05 0.0001478
530 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 15 48 1.717e-05 0.0001507
531 MESONEPHROS DEVELOPMENT 22 90 1.797e-05 0.0001575
532 DEFENSE RESPONSE 157 1231 1.855e-05 0.0001622
533 KIDNEY VASCULATURE DEVELOPMENT 9 19 1.926e-05 0.0001678
534 RENAL SYSTEM VASCULATURE DEVELOPMENT 9 19 1.926e-05 0.0001678
535 ION TRANSMEMBRANE TRANSPORT 112 822 1.947e-05 0.0001693
536 REGULATION OF INTERFERON GAMMA PRODUCTION 23 97 1.991e-05 0.0001728
537 VENTRICULAR SEPTUM MORPHOGENESIS 11 28 2.03e-05 0.0001759
538 REGIONALIZATION 52 311 2.061e-05 0.0001783
539 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 18 66 2.093e-05 0.00018
540 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 18 66 2.093e-05 0.00018
541 POSITIVE REGULATION OF ORGAN GROWTH 13 38 2.097e-05 0.00018
542 LENS DEVELOPMENT IN CAMERA TYPE EYE 18 66 2.093e-05 0.00018
543 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 12 33 2.15e-05 0.0001842
544 ENSHEATHMENT OF NEURONS 22 91 2.165e-05 0.0001849
545 AXON ENSHEATHMENT 22 91 2.165e-05 0.0001849
546 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 15 49 2.263e-05 0.0001925
547 CARDIAC SEPTUM MORPHOGENESIS 15 49 2.263e-05 0.0001925
548 HEART PROCESS 21 85 2.327e-05 0.0001976
549 NEGATIVE REGULATION OF KINASE ACTIVITY 44 250 2.448e-05 0.0002074
550 CELLULAR RESPONSE TO INSULIN STIMULUS 30 146 2.464e-05 0.0002084
551 GLIOGENESIS 34 175 2.537e-05 0.0002143
552 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 10 24 2.642e-05 0.0002227
553 REGULATION OF VESICLE MEDIATED TRANSPORT 70 462 2.696e-05 0.0002269
554 REGENERATION 32 161 2.71e-05 0.0002276
555 CELL MATRIX ADHESION 26 119 2.773e-05 0.0002325
556 MYELOID LEUKOCYTE MIGRATION 23 99 2.827e-05 0.0002366
557 REGULATION OF PHOSPHOLIPASE C ACTIVITY 13 39 2.88e-05 0.0002401
558 LONG TERM SYNAPTIC POTENTIATION 13 39 2.88e-05 0.0002401
559 REGULATION OF ADHERENS JUNCTION ORGANIZATION 15 50 2.958e-05 0.0002462
560 NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE 7 12 3.018e-05 0.0002499
561 AXON EXTENSION INVOLVED IN AXON GUIDANCE 7 12 3.018e-05 0.0002499
562 REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 7 12 3.018e-05 0.0002499
563 REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 31 155 3.167e-05 0.0002617
564 REGULATION OF DENDRITIC SPINE DEVELOPMENT 16 56 3.177e-05 0.0002621
565 AXONAL FASCICULATION 9 20 3.214e-05 0.0002647
566 POSITIVE REGULATION OF CELL GROWTH 30 148 3.234e-05 0.0002654
567 REGULATION OF DENDRITE DEVELOPMENT 26 120 3.232e-05 0.0002654
568 ORGAN GROWTH 18 68 3.254e-05 0.0002665
569 CATION TRANSPORT 108 796 3.268e-05 0.0002673
570 EXOCRINE SYSTEM DEVELOPMENT 14 45 3.45e-05 0.0002812
571 HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 14 45 3.45e-05 0.0002812
572 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 20 81 3.647e-05 0.0002966
573 NEGATIVE REGULATION OF IMMUNE RESPONSE 26 121 3.759e-05 0.0003053
574 ADULT BEHAVIOR 28 135 3.797e-05 0.0003078
575 NEGATIVE REGULATION OF CHEMOTAXIS 15 51 3.835e-05 0.0003103
576 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 19 75 3.866e-05 0.0003123
577 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 13 40 3.906e-05 0.000315
578 EPITHELIAL CELL DEVELOPMENT 35 186 3.918e-05 0.0003154
579 CELLULAR EXTRAVASATION 10 25 4.038e-05 0.0003234
580 POSTSYNAPTIC MEMBRANE ORGANIZATION 10 25 4.038e-05 0.0003234
581 PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 10 25 4.038e-05 0.0003234
582 OVULATION CYCLE PROCESS 21 88 4.067e-05 0.0003251
583 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 38 209 4.119e-05 0.0003287
584 ANTERIOR POSTERIOR PATTERN SPECIFICATION 36 194 4.162e-05 0.0003316
585 RESPONSE TO MONOAMINE 12 35 4.242e-05 0.0003374
586 SMOOTH MUSCLE CELL DIFFERENTIATION 11 30 4.337e-05 0.0003438
587 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 11 30 4.337e-05 0.0003438
588 GLIAL CELL DIFFERENTIATION 28 136 4.365e-05 0.0003454
589 NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 23 102 4.678e-05 0.0003696
590 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 39 218 4.768e-05 0.000376
591 POSITIVE REGULATION OF SECRETION 58 370 4.898e-05 0.0003857
592 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 18 70 4.953e-05 0.0003893
593 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 38 211 5.104e-05 0.0004005
594 COCHLEA MORPHOGENESIS 9 21 5.163e-05 0.0004044
595 CELL SUBSTRATE JUNCTION ASSEMBLY 13 41 5.238e-05 0.0004096
596 CALCIUM ION TRANSMEMBRANE TRANSPORT 31 159 5.281e-05 0.0004123
597 SEX DIFFERENTIATION 45 266 5.405e-05 0.0004213
598 NEGATIVE REGULATION OF GENE EXPRESSION 182 1493 5.569e-05 0.0004333
599 NEGATIVE REGULATION OF CELL CELL ADHESION 28 138 5.736e-05 0.0004456
600 T CELL PROLIFERATION 12 36 5.83e-05 0.0004521
601 INDUCTION OF POSITIVE CHEMOTAXIS 7 13 6.015e-05 0.0004657
602 CYCLIC NUCLEOTIDE CATABOLIC PROCESS 8 17 6.048e-05 0.0004667
603 EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS 8 17 6.048e-05 0.0004667
604 RESPONSE TO INSULIN 37 205 6.07e-05 0.0004676
605 REGULATION OF CHEMOKINE PRODUCTION 17 65 6.312e-05 0.0004847
606 NEGATIVE REGULATION OF AXONOGENESIS 17 65 6.312e-05 0.0004847
607 RESPONSE TO ESTRADIOL 29 146 6.398e-05 0.0004905
608 REGULATION OF TRANSPORTER ACTIVITY 36 198 6.48e-05 0.0004959
609 CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 28 139 6.558e-05 0.000501
610 RESPONSE TO EXTRACELLULAR STIMULUS 66 441 6.617e-05 0.0005047
611 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 25 118 6.718e-05 0.0005116
612 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 19 78 6.911e-05 0.0005254
613 CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL 13 42 6.946e-05 0.0005264
614 CALCIUM ION IMPORT INTO CYTOSOL 13 42 6.946e-05 0.0005264
615 CEREBRAL CORTEX DEVELOPMENT 23 105 7.549e-05 0.0005702
616 ODONTOGENESIS 23 105 7.549e-05 0.0005702
617 FOREBRAIN GENERATION OF NEURONS 17 66 7.776e-05 0.0005845
618 POSITIVE REGULATION OF LIPASE ACTIVITY 17 66 7.776e-05 0.0005845
619 RESPONSE TO CYTOKINE 97 714 7.759e-05 0.0005845
620 NEGATIVE REGULATION OF MUSCLE CONTRACTION 9 22 8.02e-05 0.0005971
621 TRANSMISSION OF NERVE IMPULSE 15 54 7.974e-05 0.0005971
622 CARDIAC MUSCLE TISSUE MORPHOGENESIS 15 54 7.974e-05 0.0005971
623 MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY 16 60 7.992e-05 0.0005971
624 SOMATIC STEM CELL DIVISION 9 22 8.02e-05 0.0005971
625 AORTA MORPHOGENESIS 9 22 8.02e-05 0.0005971
626 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 21 92 8.154e-05 0.0006061
627 CELL RECOGNITION 29 148 8.261e-05 0.0006131
628 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 28 141 8.526e-05 0.0006317
629 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 35 193 8.582e-05 0.0006348
630 SALIVARY GLAND DEVELOPMENT 11 32 8.607e-05 0.0006357
631 CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 10 27 8.768e-05 0.0006425
632 NEGATIVE REGULATION OF AXON GUIDANCE 10 27 8.768e-05 0.0006425
633 REGULATION OF CATENIN IMPORT INTO NUCLEUS 10 27 8.768e-05 0.0006425
634 SUBSTRATE DEPENDENT CELL MIGRATION 10 27 8.768e-05 0.0006425
635 AXIS ELONGATION 10 27 8.768e-05 0.0006425
636 REGULATION OF STEM CELL DIFFERENTIATION 24 113 8.939e-05 0.000654
637 REGULATION OF LEUKOCYTE MIGRATION 29 149 9.365e-05 0.0006841
638 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 183 1517 9.437e-05 0.0006882
639 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 17 67 9.53e-05 0.0006939
640 CELL DEATH 128 1001 9.893e-05 0.0007193
641 REGULATION OF KIDNEY DEVELOPMENT 15 55 0.0001003 0.0007284
642 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 12 38 0.0001059 0.000766
643 MESENCHYME MORPHOGENESIS 12 38 0.0001059 0.000766
644 TISSUE REMODELING 20 87 0.0001076 0.0007771
645 REGULATION OF ACUTE INFLAMMATORY RESPONSE 18 74 0.0001085 0.0007824
646 CAMP CATABOLIC PROCESS 7 14 0.0001107 0.0007959
647 POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY 7 14 0.0001107 0.0007959
648 REGULATION OF CELL JUNCTION ASSEMBLY 17 68 0.0001162 0.0008332
649 REGULATION OF NEUROLOGICAL SYSTEM PROCESS 17 68 0.0001162 0.0008332
650 CELL JUNCTION ASSEMBLY 26 129 0.0001165 0.0008341
651 CAMERA TYPE EYE MORPHOGENESIS 22 101 0.000117 0.0008363
652 EMBRYONIC EYE MORPHOGENESIS 11 33 0.0001184 0.0008433
653 TRANSMEMBRANE TRANSPORT 138 1098 0.0001182 0.0008433
654 CELLULAR RESPONSE TO ALCOHOL 24 115 0.0001194 0.0008495
655 CRANIAL NERVE MORPHOGENESIS 9 23 0.000121 0.0008592
656 FOREBRAIN CELL MIGRATION 16 62 0.0001222 0.0008669
657 POSITIVE REGULATION OF IMMUNE RESPONSE 79 563 0.0001237 0.0008764
658 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 85 616 0.0001246 0.0008812
659 REGULATION OF CATION CHANNEL ACTIVITY 20 88 0.0001272 0.0008983
660 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 38 220 0.0001276 0.0008994
661 REGULATION OF ADAPTIVE IMMUNE RESPONSE 25 123 0.0001359 0.0009563
662 NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS 22 102 0.0001363 0.0009567
663 RENAL SYSTEM PROCESS 22 102 0.0001363 0.0009567
664 FEMALE SEX DIFFERENTIATION 24 116 0.0001375 0.0009637
665 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 37 213 0.000138 0.0009657
666 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 12 39 0.0001401 0.0009788
667 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 17 69 0.0001411 0.0009825
668 RESPONSE TO ACTIVITY 17 69 0.0001411 0.0009825
669 POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 32 175 0.0001441 0.001002
670 PLACENTA DEVELOPMENT 27 138 0.0001467 0.001019
671 RESPONSE TO INORGANIC SUBSTANCE 69 479 0.0001493 0.001035
672 RETINA DEVELOPMENT IN CAMERA TYPE EYE 26 131 0.0001516 0.001049
673 ENDOCHONDRAL BONE MORPHOGENESIS 13 45 0.0001527 0.001055
674 REGULATION OF LEUKOCYTE CHEMOTAXIS 21 96 0.0001555 0.001073
675 REGULATION OF CALCIUM ION IMPORT 22 103 0.0001584 0.001091
676 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 8 19 0.0001587 0.001091
677 ESTROUS CYCLE 8 19 0.0001587 0.001091
678 FOREBRAIN NEURON DEVELOPMENT 11 34 0.0001604 0.001101
679 PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 19 83 0.0001681 0.001152
680 REGULATION OF CYTOPLASMIC TRANSPORT 69 481 0.0001691 0.001157
681 NEURAL PRECURSOR CELL PROLIFERATION 17 70 0.0001704 0.001164
682 CELL CYCLE ARREST 29 154 0.0001712 0.001166
683 NEGATIVE REGULATION OF MOLECULAR FUNCTION 135 1079 0.000171 0.001166
684 STEM CELL DIVISION 10 29 0.0001752 0.00119
685 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 10 29 0.0001752 0.00119
686 REGULATION OF GLIOGENESIS 20 90 0.0001763 0.001196
687 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 9 24 0.0001777 0.001203
688 REPRODUCTION 158 1297 0.0001806 0.001222
689 NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 12 40 0.0001834 0.001239
690 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 50 321 0.0001841 0.001241
691 REGULATION OF LEUKOCYTE DIFFERENTIATION 39 232 0.0001885 0.001269
692 REGULATION OF HEAT GENERATION 7 15 0.0001909 0.001276
693 CELLULAR RESPONSE TO CYTOKINE STIMULUS 83 606 0.0001908 0.001276
694 NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 7 15 0.0001909 0.001276
695 NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 7 15 0.0001909 0.001276
696 VENOUS BLOOD VESSEL DEVELOPMENT 7 15 0.0001909 0.001276
697 OLFACTORY BULB INTERNEURON DEVELOPMENT 6 11 0.0001923 0.001284
698 CYCLIC NUCLEOTIDE MEDIATED SIGNALING 13 46 0.0001949 0.001299
699 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 19 84 0.0001986 0.001322
700 POSITIVE REGULATION OF DEFENSE RESPONSE 55 364 0.0002019 0.001342
701 MEMORY 21 98 0.0002109 0.001398
702 MYELOID LEUKOCYTE ACTIVATION 21 98 0.0002109 0.001398
703 NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION 11 35 0.0002145 0.00142
704 SOMITE DEVELOPMENT 18 78 0.0002219 0.001467
705 NEGATIVE REGULATION OF ION TRANSPORT 25 127 0.00023 0.001518
706 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 15 59 0.0002361 0.001556
707 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 12 41 0.0002376 0.001557
708 REGULATION OF B CELL MEDIATED IMMUNITY 12 41 0.0002376 0.001557
709 PROSTATE GLAND DEVELOPMENT 12 41 0.0002376 0.001557
710 RECEPTOR CLUSTERING 12 41 0.0002376 0.001557
711 NEGATIVE REGULATION OF CELL MATRIX ADHESION 10 30 0.0002411 0.001573
712 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 10 30 0.0002411 0.001573
713 REGULATION OF DENDRITIC SPINE MORPHOGENESIS 10 30 0.0002411 0.001573
714 EMBRYONIC HEMOPOIESIS 8 20 0.0002432 0.001574
715 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 8 20 0.0002432 0.001574
716 MIDDLE EAR MORPHOGENESIS 8 20 0.0002432 0.001574
717 LYMPH VESSEL DEVELOPMENT 8 20 0.0002432 0.001574
718 MELANOCYTE DIFFERENTIATION 8 20 0.0002432 0.001574
719 REGULATION OF MONOCYTE CHEMOTAXIS 8 20 0.0002432 0.001574
720 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 22 106 0.0002447 0.001578
721 REGULATION OF AMINE TRANSPORT 17 72 0.0002455 0.001578
722 NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION 14 53 0.0002452 0.001578
723 MESONEPHRIC TUBULE MORPHOGENESIS 14 53 0.0002452 0.001578
724 CELLULAR RESPONSE TO AMINO ACID STIMULUS 14 53 0.0002452 0.001578
725 POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 13 47 0.0002468 0.001584
726 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 33 188 0.0002532 0.001623
727 MEMBRANE ASSEMBLY 9 25 0.0002549 0.001625
728 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 9 25 0.0002549 0.001625
729 CHONDROITIN SULFATE BIOSYNTHETIC PROCESS 9 25 0.0002549 0.001625
730 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 9 25 0.0002549 0.001625
731 REGULATION OF INTRACELLULAR TRANSPORT 84 621 0.0002641 0.001681
732 REGULATION OF HEART RATE 19 86 0.0002745 0.001745
733 NEUROMUSCULAR JUNCTION DEVELOPMENT 11 36 0.0002832 0.001783
734 NEGATIVE REGULATION OF BLOOD CIRCULATION 11 36 0.0002832 0.001783
735 NEPHRON EPITHELIUM DEVELOPMENT 20 93 0.000281 0.001783
736 POSITIVE REGULATION OF AXON EXTENSION 11 36 0.0002832 0.001783
737 REGULATION OF SENSORY PERCEPTION 11 36 0.0002832 0.001783
738 LIMBIC SYSTEM DEVELOPMENT 21 100 0.0002831 0.001783
739 REGULATION OF SENSORY PERCEPTION OF PAIN 11 36 0.0002832 0.001783
740 REGULATION OF GLUCOSE IMPORT 15 60 0.0002881 0.001807
741 STEM CELL PROLIFERATION 15 60 0.0002881 0.001807
742 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 15 60 0.0002881 0.001807
743 REGULATION OF JAK STAT CASCADE 27 144 0.0003033 0.001894
744 ALPHA BETA T CELL ACTIVATION 14 54 0.0003032 0.001894
745 REGULATION OF STAT CASCADE 27 144 0.0003033 0.001894
746 REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 12 42 0.0003049 0.001899
747 REGULATION OF BONE REMODELING 12 42 0.0003049 0.001899
748 REGULATION OF LIPID KINASE ACTIVITY 13 48 0.0003101 0.001921
749 POSITIVE REGULATION OF WOUND HEALING 13 48 0.0003101 0.001921
750 REGULATION OF INTERLEUKIN 2 PRODUCTION 13 48 0.0003101 0.001921
751 POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 13 48 0.0003101 0.001921
752 REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 7 16 0.0003123 0.001922
753 EXTRACELLULAR MATRIX ASSEMBLY 7 16 0.0003123 0.001922
754 DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS 7 16 0.0003123 0.001922
755 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 7 16 0.0003123 0.001922
756 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 7 16 0.0003123 0.001922
757 REGULATION OF HORMONE SECRETION 42 262 0.0003143 0.001932
758 HINDBRAIN DEVELOPMENT 26 137 0.0003194 0.001958
759 SKELETAL MUSCLE ORGAN DEVELOPMENT 26 137 0.0003194 0.001958
760 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 28 152 0.000321 0.001966
761 REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 20 94 0.0003264 0.001994
762 MATERNAL PLACENTA DEVELOPMENT 10 31 0.0003266 0.001994
763 RESPONSE TO NUTRIENT 33 191 0.0003413 0.002081
764 NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT 6 12 0.0003545 0.002153
765 ROUNDABOUT SIGNALING PATHWAY 6 12 0.0003545 0.002153
766 ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 6 12 0.0003545 0.002153
767 REGULATION OF TYPE 2 IMMUNE RESPONSE 9 26 0.000358 0.00216
768 REPLACEMENT OSSIFICATION 9 26 0.000358 0.00216
769 VASODILATION 9 26 0.000358 0.00216
770 ENDOCHONDRAL OSSIFICATION 9 26 0.000358 0.00216
771 CELLULAR RESPONSE TO VITAMIN 9 26 0.000358 0.00216
772 RESPONSE TO FIBROBLAST GROWTH FACTOR 23 116 0.0003606 0.00217
773 SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 8 21 0.000361 0.00217
774 LIPID TRANSLOCATION 8 21 0.000361 0.00217
775 POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 18 81 0.0003648 0.00219
776 NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE 11 37 0.0003696 0.002214
777 CELLULAR RESPONSE TO EXTERNAL STIMULUS 42 264 0.0003702 0.002214
778 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 22 109 0.00037 0.002214
779 INORGANIC ION TRANSMEMBRANE TRANSPORT 79 583 0.0003758 0.002245
780 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 25 131 0.0003778 0.002252
781 REGULATION OF LIPID TRANSPORT 20 95 0.000378 0.002252
782 CYTOSKELETON ORGANIZATION 107 838 0.0003825 0.002276
783 CRANIAL NERVE DEVELOPMENT 12 43 0.0003876 0.002292
784 POSITIVE REGULATION OF CHEMOKINE PRODUCTION 13 49 0.0003866 0.002292
785 CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS 12 43 0.0003876 0.002292
786 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 36 216 0.0003861 0.002292
787 CARDIAC CELL DEVELOPMENT 13 49 0.0003866 0.002292
788 REGULATION OF HORMONE LEVELS 67 478 0.0004034 0.002382
789 REGULATION OF RECEPTOR ACTIVITY 23 117 0.0004101 0.002419
790 SENSORY PERCEPTION OF PAIN 17 75 0.0004113 0.002423
791 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 29 162 0.0004168 0.002452
792 NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 15 62 0.0004224 0.002482
793 MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY 10 32 0.0004359 0.002542
794 PATTERNING OF BLOOD VESSELS 10 32 0.0004359 0.002542
795 POSITIVE REGULATION OF CYTOKINE SECRETION 20 96 0.0004365 0.002542
796 NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 10 32 0.0004359 0.002542
797 EPITHELIAL CELL PROLIFERATION 19 89 0.0004355 0.002542
798 REACTIVE OXYGEN SPECIES METABOLIC PROCESS 20 96 0.0004365 0.002542
799 POST EMBRYONIC DEVELOPMENT 19 89 0.0004355 0.002542
800 ACTIVATION OF IMMUNE RESPONSE 61 427 0.0004377 0.002546
801 LIPID MODIFICATION 35 210 0.0004616 0.002682
802 POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS 25 133 0.000479 0.002769
803 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 13 50 0.0004787 0.002769
804 POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 25 133 0.000479 0.002769
805 VISUAL BEHAVIOR 13 50 0.0004787 0.002769
806 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 22 111 0.0004819 0.002782
807 BODY MORPHOGENESIS 12 44 0.0004885 0.002782
808 REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION 7 17 0.0004885 0.002782
809 REGULATION OF ENERGY HOMEOSTASIS 7 17 0.0004885 0.002782
810 REGULATION OF PLATELET AGGREGATION 7 17 0.0004885 0.002782
811 REGULATION OF PROTEIN KINASE A SIGNALING 7 17 0.0004885 0.002782
812 NEGATIVE REGULATION OF ANOIKIS 7 17 0.0004885 0.002782
813 NEGATIVE REGULATION OF JAK STAT CASCADE 12 44 0.0004885 0.002782
814 NEGATIVE REGULATION OF STAT CASCADE 12 44 0.0004885 0.002782
815 PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 7 17 0.0004885 0.002782
816 ENDOCRINE PROCESS 12 44 0.0004885 0.002782
817 COPULATION 7 17 0.0004885 0.002782
818 NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 9 27 0.0004931 0.002805
819 REGULATION OF INTERLEUKIN 6 PRODUCTION 21 104 0.0004947 0.002811
820 PLASMA MEMBRANE ORGANIZATION 34 203 0.000504 0.00286
821 NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 8 22 0.0005215 0.002952
822 SUBPALLIUM DEVELOPMENT 8 22 0.0005215 0.002952
823 MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS 30 172 0.0005271 0.00298
824 ACTOMYOSIN STRUCTURE ORGANIZATION 17 77 0.0005693 0.003215
825 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 105 829 0.000576 0.003248
826 SIGNAL RELEASE 30 173 0.0005823 0.00328
827 REGULATION OF VASCULOGENESIS 6 13 0.0006068 0.00339
828 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 25 135 0.0006033 0.00339
829 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 6 13 0.0006068 0.00339
830 REGULATION OF NEUROTRANSMITTER TRANSPORT 15 64 0.0006069 0.00339
831 NEGATIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS 6 13 0.0006068 0.00339
832 REGULATION OF CELL FATE SPECIFICATION 6 13 0.0006068 0.00339
833 DERMATAN SULFATE METABOLIC PROCESS 6 13 0.0006068 0.00339
834 ALPHA BETA T CELL DIFFERENTIATION 12 45 0.0006107 0.003403
835 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL 12 45 0.0006107 0.003403
836 RESPONSE TO PURINE CONTAINING COMPOUND 28 158 0.0006132 0.003413
837 REGULATION OF IMMUNE EFFECTOR PROCESS 60 424 0.0006192 0.003442
838 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 26 143 0.0006337 0.003518
839 SPINAL CORD DEVELOPMENT 21 106 0.0006445 0.003562
840 REGULATION OF FAT CELL DIFFERENTIATION 21 106 0.0006445 0.003562
841 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 16 71 0.0006443 0.003562
842 CELL FATE SPECIFICATION 16 71 0.0006443 0.003562
843 REGULATION OF NEUROTRANSMITTER LEVELS 32 190 0.0006575 0.003629
844 POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 9 28 0.0006675 0.003658
845 REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 9 28 0.0006675 0.003658
846 RENAL TUBULE DEVELOPMENT 17 78 0.0006661 0.003658
847 MUSCLE HYPERTROPHY 9 28 0.0006675 0.003658
848 POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 14 58 0.0006666 0.003658
849 NEURONAL ACTION POTENTIAL 9 28 0.0006675 0.003658
850 REGULATION OF PROTEIN KINASE B SIGNALING 23 121 0.0006728 0.003683
851 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 132 1087 0.0006921 0.003784
852 AGING 41 264 0.0007097 0.003876
853 REGULATION OF REPRODUCTIVE PROCESS 24 129 0.000717 0.003911
854 POSITIVE REGULATION OF REPRODUCTIVE PROCESS 13 52 0.0007192 0.003918
855 CELLULAR RESPONSE TO RETINOIC ACID 15 65 0.0007224 0.003922
856 CALCIUM ION IMPORT 15 65 0.0007224 0.003922
857 POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION 15 65 0.0007224 0.003922
858 PROSTATE GLAND MORPHOGENESIS 8 23 0.0007351 0.003976
859 SMOOTH MUSCLE TISSUE DEVELOPMENT 7 18 0.0007358 0.003976
860 REGULATION OF METANEPHROS DEVELOPMENT 8 23 0.0007351 0.003976
861 KIDNEY MESENCHYME DEVELOPMENT 7 18 0.0007358 0.003976
862 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 10 34 0.0007462 0.004019
863 RESPONSE TO FLUID SHEAR STRESS 10 34 0.0007462 0.004019
864 HEART VALVE DEVELOPMENT 10 34 0.0007462 0.004019
865 PROTEIN TRIMERIZATION 11 40 0.0007709 0.004142
866 ENDODERMAL CELL DIFFERENTIATION 11 40 0.0007709 0.004142
867 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 27 153 0.0008121 0.004358
868 NEGATIVE REGULATION OF PROTEIN SECRETION 21 108 0.0008321 0.004461
869 ENDOCYTOSIS 69 509 0.000846 0.00453
870 REGULATION OF CARDIAC MUSCLE CONTRACTION 15 66 0.000856 0.004573
871 REGULATION OF CARDIAC CONDUCTION 15 66 0.000856 0.004573
872 REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 20 101 0.0008627 0.004604
873 NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 9 29 0.000889 0.004711
874 ASSOCIATIVE LEARNING 16 73 0.0008889 0.004711
875 RESPONSE TO PAIN 9 29 0.000889 0.004711
876 REGULATION OF EXCRETION 9 29 0.000889 0.004711
877 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 9 29 0.000889 0.004711
878 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 16 73 0.0008889 0.004711
879 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 14 60 0.0009564 0.005063
880 NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 10 35 0.0009589 0.005065
881 POSITIVE REGULATION OF HEART CONTRACTION 10 35 0.0009589 0.005065
882 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 11 41 0.0009665 0.005099
883 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 88 684 0.000968 0.005101
884 POSITIVE REGULATION OF METANEPHROS DEVELOPMENT 6 14 0.0009789 0.005112
885 INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 6 14 0.0009789 0.005112
886 NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 6 14 0.0009789 0.005112
887 REGULATION OF GLOMERULUS DEVELOPMENT 6 14 0.0009789 0.005112
888 METANEPHRIC MESENCHYME DEVELOPMENT 6 14 0.0009789 0.005112
889 CONVERGENT EXTENSION 6 14 0.0009789 0.005112
890 CRANIOFACIAL SUTURE MORPHOGENESIS 6 14 0.0009789 0.005112
891 CELLULAR RESPONSE TO VITAMIN D 6 14 0.0009789 0.005112
892 SENSORY PERCEPTION OF MECHANICAL STIMULUS 27 155 0.0009952 0.005191
893 POSITIVE REGULATION OF HEMOPOIESIS 28 163 0.001013 0.005247
894 CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 8 24 0.001014 0.005247
895 CANONICAL WNT SIGNALING PATHWAY 19 95 0.001013 0.005247
896 MAMMARY GLAND DEVELOPMENT 22 117 0.001012 0.005247
897 REGULATION OF NOTCH SIGNALING PATHWAY 15 67 0.00101 0.005247
898 NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 8 24 0.001014 0.005247
899 CELLULAR RESPONSE TO DRUG 15 67 0.00101 0.005247
900 POSITIVE REGULATION OF PROTEIN SECRETION 34 211 0.001018 0.005261
901 ESTABLISHMENT OF CELL POLARITY 18 88 0.001036 0.005349
902 REGULATION OF DENDRITE MORPHOGENESIS 16 74 0.001038 0.005355
903 PHENOL CONTAINING COMPOUND METABOLIC PROCESS 17 81 0.001045 0.005381
904 REGULATION OF JUN KINASE ACTIVITY 17 81 0.001045 0.005381
905 REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 7 19 0.001072 0.005489
906 THYMIC T CELL SELECTION 7 19 0.001072 0.005489
907 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 7 19 0.001072 0.005489
908 REGULATION OF ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLE PROPIONATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY 7 19 0.001072 0.005489
909 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 7 19 0.001072 0.005489
910 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 27 156 0.001099 0.005615
911 REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 27 156 0.001099 0.005615
912 RESPONSE TO AXON INJURY 12 48 0.00114 0.005803
913 REGULATION OF ENDOCRINE PROCESS 12 48 0.00114 0.005803
914 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 12 48 0.00114 0.005803
915 MYELOID LEUKOCYTE DIFFERENTIATION 19 96 0.001156 0.005878
916 MEMBRANE BIOGENESIS 9 30 0.001167 0.005913
917 CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS 9 30 0.001167 0.005913
918 POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 9 30 0.001167 0.005913
919 AMINOGLYCAN CATABOLIC PROCESS 15 68 0.001187 0.006008
920 CATECHOLAMINE METABOLIC PROCESS 11 42 0.001201 0.006043
921 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 11 42 0.001201 0.006043
922 POSITIVE REGULATION OF GLUCOSE TRANSPORT 11 42 0.001201 0.006043
923 EPITHELIAL CELL MORPHOGENESIS 11 42 0.001201 0.006043
924 CATECHOL CONTAINING COMPOUND METABOLIC PROCESS 11 42 0.001201 0.006043
925 GENITALIA DEVELOPMENT 11 42 0.001201 0.006043
926 GRANULOCYTE MIGRATION 16 75 0.001208 0.006058
927 CARDIAC CONDUCTION 17 82 0.001207 0.006058
928 NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 17 82 0.001207 0.006058
929 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 10 36 0.001219 0.006078
930 CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 10 36 0.001219 0.006078
931 OLFACTORY LOBE DEVELOPMENT 10 36 0.001219 0.006078
932 SEMAPHORIN PLEXIN SIGNALING PATHWAY 10 36 0.001219 0.006078
933 HEAD MORPHOGENESIS 10 36 0.001219 0.006078
934 MYELOID CELL DIFFERENTIATION 31 189 0.001236 0.00616
935 REGULATION OF HEMOPOIESIS 46 314 0.001243 0.006185
936 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 24 134 0.001247 0.006199
937 POSITIVE REGULATION OF PROTEIN IMPORT 20 104 0.001261 0.006263
938 ACTIN CYTOSKELETON REORGANIZATION 13 55 0.001265 0.006275
939 REGULATION OF LEUKOCYTE PROLIFERATION 33 206 0.001324 0.006558
940 POSITIVE REGULATION OF COAGULATION 8 25 0.001371 0.006757
941 REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 8 25 0.001371 0.006757
942 DOPAMINE METABOLIC PROCESS 8 25 0.001371 0.006757
943 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 8 25 0.001371 0.006757
944 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM 8 25 0.001371 0.006757
945 REGULATION OF PROTEIN TARGETING 45 307 0.001379 0.006788
946 REGULATION OF NEURONAL SYNAPTIC PLASTICITY 12 49 0.001384 0.006809
947 RESPONSE TO FATTY ACID 17 83 0.001389 0.006826
948 EXTRACELLULAR MATRIX DISASSEMBLY 16 76 0.001401 0.006877
949 PROTEIN LOCALIZATION TO CELL PERIPHERY 26 151 0.001452 0.007121
950 REGULATION OF CATECHOLAMINE SECRETION 11 43 0.001481 0.007246
951 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 11 43 0.001481 0.007246
952 HOMEOSTASIS OF NUMBER OF CELLS 29 175 0.001484 0.007254
953 HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 19 98 0.001492 0.007268
954 OLFACTORY BULB INTERNEURON DIFFERENTIATION 6 15 0.001504 0.007268
955 OTIC VESICLE DEVELOPMENT 6 15 0.001504 0.007268
956 INTERLEUKIN 1 PRODUCTION 6 15 0.001504 0.007268
957 MORPHOGENESIS OF AN EPITHELIAL FOLD 6 15 0.001504 0.007268
958 NOSE DEVELOPMENT 6 15 0.001504 0.007268
959 REGULATION OF MESODERM DEVELOPMENT 6 15 0.001504 0.007268
960 BLASTODERM SEGMENTATION 6 15 0.001504 0.007268
961 LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE 19 98 0.001492 0.007268
962 AMINO ACID IMPORT 6 15 0.001504 0.007268
963 POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS 6 15 0.001504 0.007268
964 MACROPHAGE ACTIVATION 9 31 0.00151 0.007282
965 POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION 9 31 0.00151 0.007282
966 TONGUE DEVELOPMENT 7 20 0.001519 0.007301
967 REFLEX 7 20 0.001519 0.007301
968 PARTURITION 7 20 0.001519 0.007301
969 MATING 10 37 0.001533 0.007333
970 REGULATION OF MEMBRANE LIPID DISTRIBUTION 10 37 0.001533 0.007333
971 CARDIAC MUSCLE CELL ACTION POTENTIAL 10 37 0.001533 0.007333
972 ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY 10 37 0.001533 0.007333
973 ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY 10 37 0.001533 0.007333
974 NEUROEPITHELIAL CELL DIFFERENTIATION 14 63 0.001585 0.007564
975 POSITIVE REGULATION OF JUN KINASE ACTIVITY 14 63 0.001585 0.007564
976 GLYCOPROTEIN METABOLIC PROCESS 50 353 0.001647 0.007853
977 REGULATION OF CAMP METABOLIC PROCESS 23 129 0.001657 0.007893
978 FACE DEVELOPMENT 12 50 0.00167 0.007938
979 ENDODERM FORMATION 12 50 0.00167 0.007938
980 STRIATED MUSCLE CONTRACTION 19 99 0.001689 0.008021
981 RESPONSE TO ALKALOID 24 137 0.001705 0.008086
982 ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 25 145 0.00174 0.008242
983 DEVELOPMENTAL MATURATION 31 193 0.001743 0.008251
984 POSITIVE REGULATION OF MUSCLE CONTRACTION 11 44 0.001812 0.00855
985 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 11 44 0.001812 0.00855
986 NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 11 44 0.001812 0.00855
987 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 8 26 0.001821 0.008568
988 MESODERMAL CELL DIFFERENTIATION 8 26 0.001821 0.008568
989 REGULATION OF CELL FATE COMMITMENT 8 26 0.001821 0.008568
990 POSITIVE REGULATION OF DENDRITE DEVELOPMENT 14 64 0.001859 0.008737
991 REGULATION OF ANION TRANSPORT 24 138 0.001886 0.008857
992 NEGATIVE REGULATION OF AXON EXTENSION 10 38 0.001911 0.008935
993 BONE MINERALIZATION 10 38 0.001911 0.008935
994 NEGATIVE REGULATION OF INFLAMMATORY RESPONSE 19 100 0.001908 0.008935
995 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 19 100 0.001908 0.008935
996 POSITIVE REGULATION OF LIPID KINASE ACTIVITY 9 32 0.001931 0.009002
997 REGULATION OF ORGAN FORMATION 9 32 0.001931 0.009002
998 BLOOD VESSEL REMODELING 9 32 0.001931 0.009002
999 POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 5 11 0.001946 0.009011
1000 REGULATION OF T HELPER 2 CELL DIFFERENTIATION 5 11 0.001946 0.009011
1001 NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 5 11 0.001946 0.009011
1002 REGULATION OF FEVER GENERATION 5 11 0.001946 0.009011
1003 ENTERIC NERVOUS SYSTEM DEVELOPMENT 5 11 0.001946 0.009011
1004 POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 5 11 0.001946 0.009011
1005 BASEMENT MEMBRANE ORGANIZATION 5 11 0.001946 0.009011
1006 REGULATION OF NEUROTRANSMITTER SECRETION 12 51 0.002003 0.009209
1007 ACTIN FILAMENT BASED MOVEMENT 18 93 0.002001 0.009209
1008 POSITIVE REGULATION OF LIPID TRANSPORT 12 51 0.002003 0.009209
1009 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 12 51 0.002003 0.009209
1010 CELLULAR RESPONSE TO FATTY ACID 12 51 0.002003 0.009209
1011 REGULATION OF INTERLEUKIN 12 PRODUCTION 12 51 0.002003 0.009209
1012 POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION 12 51 0.002003 0.009209
1013 DENDRITIC CELL MIGRATION 7 21 0.002098 0.009626
1014 CELL DIFFERENTIATION IN HINDBRAIN 7 21 0.002098 0.009626
1015 PROTEIN SECRETION 21 116 0.002127 0.009749
1016 ADAPTIVE IMMUNE RESPONSE 42 288 0.00215 0.009847
NumGOOverlapSizeP ValueAdj. P Value
1 RECEPTOR BINDING 254 1476 1.244e-23 1.156e-20
2 GLYCOSAMINOGLYCAN BINDING 65 205 1.423e-19 6.61e-17
3 HEPARIN BINDING 53 157 1.517e-17 4.698e-15
4 GROWTH FACTOR BINDING 45 123 1.272e-16 2.955e-14
5 CALCIUM ION BINDING 131 697 1.877e-15 3.488e-13
6 CELL ADHESION MOLECULE BINDING 55 186 2.701e-15 4.182e-13
7 SULFUR COMPOUND BINDING 61 234 4.999e-14 6.634e-12
8 MOLECULAR FUNCTION REGULATOR 203 1353 1.357e-12 1.576e-10
9 INTEGRIN BINDING 33 105 1.621e-10 1.674e-08
10 CYTOSKELETAL PROTEIN BINDING 129 819 1.064e-09 9.083e-08
11 ACTIN BINDING 75 393 1.075e-09 9.083e-08
12 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 27 81 1.713e-09 1.18e-07
13 CYTOKINE BINDING 29 92 1.905e-09 1.18e-07
14 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 26 76 1.812e-09 1.18e-07
15 PROTEIN COMPLEX BINDING 142 935 1.835e-09 1.18e-07
16 MACROMOLECULAR COMPLEX BINDING 195 1399 2.333e-09 1.354e-07
17 SIGNAL TRANSDUCER ACTIVITY 231 1731 3.577e-09 1.954e-07
18 RECEPTOR ACTIVITY 219 1649 1.447e-08 7.467e-07
19 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 23 70 3.694e-08 1.806e-06
20 ENZYME REGULATOR ACTIVITY 139 959 5.359e-08 2.489e-06
21 PROTEIN KINASE ACTIVITY 101 640 6.547e-08 2.839e-06
22 KINASE ACTIVITY 125 842 6.723e-08 2.839e-06
23 GATED CHANNEL ACTIVITY 61 325 7.153e-08 2.889e-06
24 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 165 1199 1.048e-07 4.058e-06
25 GROWTH FACTOR ACTIVITY 37 160 1.374e-07 5.105e-06
26 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 21 64 1.475e-07 5.271e-06
27 COLLAGEN BINDING 21 65 1.99e-07 6.847e-06
28 TRANSFORMING GROWTH FACTOR BETA BINDING 10 16 2.161e-07 7.171e-06
29 FIBRONECTIN BINDING 13 28 3.512e-07 1.125e-05
30 VOLTAGE GATED ION CHANNEL ACTIVITY 40 190 6.189e-07 1.917e-05
31 PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 76 464 6.508e-07 1.926e-05
32 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 96 629 6.634e-07 1.926e-05
33 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 58 328 1.158e-06 3.261e-05
34 PROTEIN TYROSINE KINASE ACTIVITY 37 176 1.668e-06 4.558e-05
35 CHEMOREPELLENT ACTIVITY 12 27 1.785e-06 4.738e-05
36 CATION CHANNEL ACTIVITY 53 298 2.765e-06 7.135e-05
37 SIGNALING RECEPTOR ACTIVITY 179 1393 2.939e-06 7.38e-05
38 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 15 43 3.714e-06 9.081e-05
39 ENZYME ACTIVATOR ACTIVITY 74 471 4.386e-06 0.0001045
40 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY 11 25 5.475e-06 0.0001272
41 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 54 315 6.896e-06 0.0001563
42 KINASE BINDING 89 606 8.216e-06 0.0001817
43 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 52 303 9.808e-06 0.0002119
44 CYCLIC NUCLEOTIDE BINDING 13 36 1.068e-05 0.0002254
45 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 42 228 1.2e-05 0.0002478
46 G PROTEIN COUPLED RECEPTOR BINDING 46 259 1.272e-05 0.0002568
47 CHEMOATTRACTANT ACTIVITY 11 27 1.345e-05 0.0002647
48 PLATELET DERIVED GROWTH FACTOR BINDING 7 11 1.368e-05 0.0002647
49 PHOSPHORIC DIESTER HYDROLASE ACTIVITY 22 90 1.797e-05 0.0003408
50 X3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY 8 15 1.897e-05 0.0003524
51 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 41 226 2.205e-05 0.0004017
52 PROTEIN DOMAIN SPECIFIC BINDING 89 624 2.57e-05 0.0004591
53 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 15 51 3.835e-05 0.0006722
54 INSULIN LIKE GROWTH FACTOR BINDING 10 25 4.038e-05 0.0006821
55 GLYCOPROTEIN BINDING 23 101 3.967e-05 0.0006821
56 PROTEOGLYCAN BINDING 11 30 4.337e-05 0.0007147
57 GROWTH FACTOR RECEPTOR BINDING 27 129 4.385e-05 0.0007147
58 CYTOKINE RECEPTOR ACTIVITY 21 89 4.863e-05 0.000779
59 BETA CATENIN BINDING 20 84 6.366e-05 0.001002
60 PROTEIN DIMERIZATION ACTIVITY 145 1149 6.539e-05 0.001009
61 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 128 992 6.628e-05 0.001009
62 IDENTICAL PROTEIN BINDING 151 1209 7.705e-05 0.001154
63 METALLOENDOPEPTIDASE ACTIVITY 24 113 8.939e-05 0.001318
64 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 52 329 9.476e-05 0.001376
65 RECEPTOR SIGNALING PROTEIN ACTIVITY 32 172 0.000103 0.001472
66 CORECEPTOR ACTIVITY 12 38 0.0001059 0.00149
67 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING 10 28 0.0001251 0.001735
68 REGULATORY REGION NUCLEIC ACID BINDING 107 818 0.0001542 0.002106
69 EXTRACELLULAR MATRIX BINDING 14 51 0.0001573 0.002118
70 PDZ DOMAIN BINDING 20 90 0.0001763 0.00234
71 PROTEIN HOMODIMERIZATION ACTIVITY 96 722 0.0001857 0.002429
72 NEUROPILIN BINDING 7 15 0.0001909 0.002429
73 PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 7 15 0.0001909 0.002429
74 HORMONE BINDING 16 65 0.000222 0.002786
75 METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 61 417 0.0002318 0.002871
76 ENZYME BINDING 203 1737 0.0002365 0.002891
77 TRANSMEMBRANE TRANSPORTER ACTIVITY 125 997 0.000272 0.003281
78 PROTEIN KINASE A BINDING 12 42 0.0003049 0.003581
79 PHOSPHOLIPID TRANSLOCATING ATPASE ACTIVITY 7 16 0.0003123 0.003581
80 LIGAND GATED CALCIUM CHANNEL ACTIVITY 7 16 0.0003123 0.003581
81 CGMP BINDING 7 16 0.0003123 0.003581
82 WNT PROTEIN BINDING 10 31 0.0003266 0.0037
83 KINASE REGULATOR ACTIVITY 32 186 0.0004496 0.005032
84 TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY 7 17 0.0004885 0.005403
85 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 19 90 0.0005048 0.005518
86 METALLOPEPTIDASE ACTIVITY 32 188 0.0005449 0.005886
87 CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 24 128 0.0006387 0.00682
88 INTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY 9 28 0.0006675 0.006967
89 HISTONE ACETYLTRANSFERASE BINDING 9 28 0.0006675 0.006967
NumGOOverlapSizeP ValueAdj. P Value
1 EXTRACELLULAR MATRIX 130 426 4.471e-36 1.641e-33
2 PROTEINACEOUS EXTRACELLULAR MATRIX 117 356 5.621e-36 1.641e-33
3 NEURON PROJECTION 192 942 1.12e-26 2.047e-24
4 CELL PROJECTION 301 1786 1.402e-26 2.047e-24
5 NEURON PART 233 1265 9.271e-26 1.083e-23
6 INTRINSIC COMPONENT OF PLASMA MEMBRANE 281 1649 1.616e-25 1.573e-23
7 MEMBRANE REGION 215 1134 1.903e-25 1.587e-23
8 CELL JUNCTION 216 1151 5.836e-25 4.26e-23
9 SYNAPSE 157 754 6.992e-23 4.537e-21
10 EXTRACELLULAR MATRIX COMPONENT 53 125 7.986e-23 4.664e-21
11 CELL SURFACE 156 757 2.902e-22 1.541e-20
12 MEMBRANE MICRODOMAIN 76 288 1.817e-17 8.845e-16
13 POSTSYNAPSE 89 378 8.209e-17 3.688e-15
14 SOMATODENDRITIC COMPARTMENT 128 650 9.282e-17 3.872e-15
15 PLASMA MEMBRANE REGION 164 929 1.951e-16 7.597e-15
16 EXTRACELLULAR SPACE 219 1376 2.552e-16 9.315e-15
17 SYNAPSE PART 120 610 9.598e-16 3.297e-14
18 DENDRITE 94 451 3.783e-14 1.227e-12
19 BASEMENT MEMBRANE 34 93 6.795e-13 2.088e-11
20 SIDE OF MEMBRANE 87 428 1.47e-12 4.292e-11
21 CELL LEADING EDGE 75 350 3.585e-12 9.97e-11
22 COLLAGEN TRIMER 32 88 3.808e-12 1.011e-10
23 AXON 84 418 6.747e-12 1.713e-10
24 CELL CELL JUNCTION 79 383 7.354e-12 1.789e-10
25 ANCHORING JUNCTION 91 489 7.263e-11 1.697e-09
26 PLASMA MEMBRANE PROTEIN COMPLEX 93 510 1.392e-10 3.126e-09
27 CELL BODY 90 494 2.909e-10 6.292e-09
28 EXCITATORY SYNAPSE 48 197 3.075e-10 6.413e-09
29 CELL PROJECTION PART 143 946 2.201e-09 4.433e-08
30 RECEPTOR COMPLEX 65 327 2.578e-09 5.018e-08
31 SYNAPTIC MEMBRANE 54 261 1.358e-08 2.558e-07
32 COMPLEX OF COLLAGEN TRIMERS 13 23 1.673e-08 3.054e-07
33 SARCOLEMMA 33 125 2.2e-08 3.893e-07
34 CELL SUBSTRATE JUNCTION 72 398 2.377e-08 4.082e-07
35 EXTERNAL SIDE OF PLASMA MEMBRANE 50 238 2.762e-08 4.608e-07
36 POSTSYNAPTIC MEMBRANE 45 205 3.428e-08 5.56e-07
37 EXTRINSIC COMPONENT OF MEMBRANE 51 252 7.185e-08 1.134e-06
38 PLASMA MEMBRANE RAFT 25 86 1.459e-07 2.242e-06
39 CELL CELL ADHERENS JUNCTION 19 54 1.645e-07 2.463e-06
40 FILOPODIUM 26 94 2.467e-07 3.601e-06
41 INTRACELLULAR VESICLE 168 1259 6.029e-07 8.587e-06
42 FIBRIL 9 14 6.42e-07 8.927e-06
43 LAMELLIPODIUM 37 172 9.293e-07 1.262e-05
44 I BAND 29 121 1.381e-06 1.833e-05
45 PLATELET ALPHA GRANULE 21 75 2.783e-06 3.612e-05
46 CYTOPLASMIC VESICLE PART 90 601 3.298e-06 4.186e-05
47 AXON PART 42 219 4.244e-06 5.273e-05
48 CYTOPLASMIC SIDE OF MEMBRANE 35 170 5.162e-06 6.281e-05
49 ENDOPLASMIC RETICULUM LUMEN 39 201 6.909e-06 8.235e-05
50 CONTRACTILE FIBER 40 211 9.49e-06 0.0001108
51 CELL PROJECTION MEMBRANE 51 298 1.287e-05 0.0001473
52 CELL CELL CONTACT ZONE 18 64 1.317e-05 0.000148
53 NEURONAL POSTSYNAPTIC DENSITY 16 53 1.48e-05 0.0001631
54 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 29 136 1.606e-05 0.0001737
55 SECRETORY GRANULE LUMEN 21 85 2.327e-05 0.0002471
56 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 23 98 2.376e-05 0.0002478
57 SECRETORY VESICLE 70 461 2.51e-05 0.0002527
58 PLATELET ALPHA GRANULE LUMEN 16 55 2.481e-05 0.0002527
59 BANDED COLLAGEN FIBRIL 7 12 3.018e-05 0.0002988
60 LEADING EDGE MEMBRANE 28 134 3.296e-05 0.0003208
61 RUFFLE 31 156 3.607e-05 0.0003453
62 SITE OF POLARIZED GROWTH 30 149 3.696e-05 0.0003481
63 NEURON SPINE 26 121 3.759e-05 0.0003485
64 PERIKARYON 24 108 4.158e-05 0.0003794
65 SECRETORY GRANULE 56 352 4.328e-05 0.0003889
66 ACTIN BASED CELL PROJECTION 34 181 5.204e-05 0.0004605
67 ACTIN CYTOSKELETON 66 444 8.132e-05 0.0007088
68 VESICLE LUMEN 23 106 8.807e-05 0.0007564
69 INTERSTITIAL MATRIX 7 14 0.0001107 0.0009366
70 PRESYNAPSE 46 283 0.0001203 0.001004
71 ACTOMYOSIN 16 62 0.0001222 0.001005
72 PLASMA MEMBRANE RECEPTOR COMPLEX 32 175 0.0001441 0.001169
73 MEMBRANE PROTEIN COMPLEX 129 1020 0.0001504 0.001203
74 INTERCALATED DISC 14 51 0.0001573 0.001241
75 CYTOPLASMIC REGION 46 287 0.0001681 0.001309
76 TRANSPORTER COMPLEX 50 321 0.0001841 0.001414
77 AXONAL GROWTH CONE 8 20 0.0002432 0.001844
78 NEURON PROJECTION TERMINUS 25 129 0.0002958 0.002215
79 NEUROMUSCULAR JUNCTION 14 54 0.0003032 0.002241
80 RUFFLE MEMBRANE 18 80 0.0003102 0.002264
81 CATION CHANNEL COMPLEX 30 167 0.0003145 0.002268
82 GLYCOPROTEIN COMPLEX 8 21 0.000361 0.002571
83 T TUBULE 12 45 0.0006107 0.004297
84 ENDOCYTIC VESICLE MEMBRANE 27 152 0.0007321 0.00509
85 APICAL PLASMA MEMBRANE 44 292 0.0008805 0.00605
86 VOLTAGE GATED SODIUM CHANNEL COMPLEX 6 14 0.0009789 0.006647
87 VESICLE MEMBRANE 69 512 0.0009907 0.00665
88 GOLGI APPARATUS 168 1445 0.001041 0.006908
89 PERINUCLEAR REGION OF CYTOPLASM 83 642 0.001153 0.007568
90 CELL CORTEX 37 238 0.001232 0.007997
91 LYTIC VACUOLE 70 526 0.001281 0.008219
92 PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX 7 20 0.001519 0.009641
93 APICAL PART OF CELL 51 361 0.001577 0.009901

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 PI3K_Akt_signaling_pathway_hsa04151 83 352 8.356e-16 4.345e-14
2 Focal_adhesion_hsa04510 55 199 6.342e-14 1.649e-12
3 Rap1_signaling_pathway_hsa04015 54 206 1.105e-12 1.916e-11
4 Ras_signaling_pathway_hsa04014 54 232 1.546e-10 2.01e-09
5 mTOR_signaling_pathway_hsa04150 39 151 2.359e-09 2.453e-08
6 Cell_adhesion_molecules_.CAMs._hsa04514 37 145 8.579e-09 7.331e-08
7 cAMP_signaling_pathway_hsa04024 45 198 1.122e-08 7.331e-08
8 ECM_receptor_interaction_hsa04512 26 82 1.128e-08 7.331e-08
9 MAPK_signaling_pathway_hsa04010 58 295 2.763e-08 1.597e-07
10 Cytokine_cytokine_receptor_interaction_hsa04060 54 270 4.545e-08 2.364e-07
11 cGMP_PKG_signaling_pathway_hsa04022 37 163 2.268e-07 1.016e-06
12 Apelin_signaling_pathway_hsa04371 33 137 2.345e-07 1.016e-06
13 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 33 139 3.362e-07 1.345e-06
14 Regulation_of_actin_cytoskeleton_hsa04810 43 208 4.042e-07 1.501e-06
15 Calcium_signaling_pathway_hsa04020 39 182 5.298e-07 1.837e-06
16 Phospholipase_D_signaling_pathway_hsa04072 32 146 3.241e-06 1.053e-05
17 HIF_1_signaling_pathway_hsa04066 24 100 1.064e-05 3.256e-05
18 Wnt_signaling_pathway_hsa04310 30 146 2.464e-05 7.117e-05
19 Hippo_signaling_pathway_hsa04390 31 154 2.776e-05 7.598e-05
20 TGF_beta_signaling_pathway_hsa04350 20 84 6.366e-05 0.0001652
21 FoxO_signaling_pathway_hsa04068 27 132 6.671e-05 0.0001652
22 AMPK_signaling_pathway_hsa04152 25 121 0.0001032 0.0002438
23 Gap_junction_hsa04540 20 88 0.0001272 0.0002876
24 Phagosome_hsa04145 29 152 0.0001351 0.0002928
25 Autophagy_animal_hsa04140 25 128 0.0002611 0.0005431
26 Neuroactive_ligand_receptor_interaction_hsa04080 43 278 0.0005817 0.001163
27 Sphingolipid_signaling_pathway_hsa04071 22 118 0.001137 0.00219
28 Tight_junction_hsa04530 27 170 0.003899 0.007095
29 Jak_STAT_signaling_pathway_hsa04630 26 162 0.003957 0.007095
30 ErbB_signaling_pathway_hsa04012 16 85 0.004611 0.007992
31 Adherens_junction_hsa04520 14 72 0.005779 0.009693
32 Hippo_signaling_pathway_multiple_species_hsa04392 7 29 0.01463 0.02377
33 VEGF_signaling_pathway_hsa04370 11 59 0.01838 0.02896
34 Phosphatidylinositol_signaling_system_hsa04070 16 99 0.01951 0.02984
35 ABC_transporters_hsa02010 9 45 0.02051 0.03047
36 Cellular_senescence_hsa04218 22 160 0.03934 0.05682
37 NF_kappa_B_signaling_pathway_hsa04064 13 95 0.09916 0.1394
38 TNF_signaling_pathway_hsa04668 14 108 0.1246 0.1706
39 Hedgehog_signaling_pathway_hsa04340 7 47 0.1406 0.1874
40 Ferroptosis_hsa04216 6 40 0.1613 0.2096
41 Oocyte_meiosis_hsa04114 14 124 0.2577 0.3269
42 Apoptosis_hsa04210 15 138 0.2966 0.3672
43 p53_signaling_pathway_hsa04115 7 68 0.4441 0.5371
44 Endocytosis_hsa04144 23 244 0.4976 0.5881
45 Notch_signaling_pathway_hsa04330 4 48 0.6611 0.764
46 Lysosome_hsa04142 10 123 0.7134 0.8064
47 Mitophagy_animal_hsa04137 5 65 0.7314 0.8092
48 Autophagy_other_hsa04136 2 32 0.8101 0.8776
49 Peroxisome_hsa04146 3 83 0.9861 0.9976
50 Necroptosis_hsa04217 8 164 0.9876 0.9976
51 Cell_cycle_hsa04110 4 124 0.9976 0.9976

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-1275;hsa-miR-130b-3p;hsa-miR-148a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-224-3p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-374b-3p;hsa-miR-421;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-486-5p;hsa-miR-576-5p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-592;hsa-miR-629-5p;hsa-miR-940 31 IGF1 Sponge network 0.757 0.32745 0.235 0.63995 0.587
2

EMX2OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-1275;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-374b-5p;hsa-miR-421;hsa-miR-424-5p;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-502-5p;hsa-miR-505-3p;hsa-miR-548o-3p;hsa-miR-577;hsa-miR-663b;hsa-miR-93-5p 27 AKT3 Sponge network 0.757 0.32745 0.4 0.44923 0.542
3

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-1275;hsa-miR-130b-3p;hsa-miR-148a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-320a;hsa-miR-33a-3p;hsa-miR-361-5p;hsa-miR-362-5p;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-592;hsa-miR-629-5p;hsa-miR-940 28 IGF1 Sponge network 0.758 0.26055 0.235 0.63995 0.513
4

CECR7

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-1275;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-28-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-320a;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-362-5p;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-502-5p;hsa-miR-93-5p 22 AKT3 Sponge network 0.758 0.26055 0.4 0.44923 0.508
5

MIAT

 hsa-miR-130b-3p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-301a-3p;hsa-miR-362-5p;hsa-miR-374b-3p;hsa-miR-421;hsa-miR-452-5p;hsa-miR-454-3p 11 IGF1 Sponge network -0.409 0.38894 0.235 0.63995 0.431
6

MEG3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-320c;hsa-miR-335-3p;hsa-miR-362-5p;hsa-miR-577;hsa-miR-663b;hsa-miR-93-5p 18 AKT3 Sponge network -0.118 0.73645 0.4 0.44923 0.405
7

MEG3

 hsa-miR-130b-3p;hsa-miR-148a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-362-5p;hsa-miR-374b-3p;hsa-miR-576-5p;hsa-miR-577 16 IGF1 Sponge network -0.118 0.73645 0.235 0.63995 0.37
8

CECR7

 hsa-let-7f-1-3p;hsa-miR-148a-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-32-3p;hsa-miR-335-5p;hsa-miR-582-3p;hsa-miR-590-3p;hsa-miR-590-5p 11 PIK3CA Sponge network 0.758 0.26055 0.179 0.76687 0.368
9

CECR7

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-26b-5p;hsa-miR-30c-5p;hsa-miR-32-3p;hsa-miR-331-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-93-5p 35 PRKAA2 Sponge network 0.758 0.26055 1.488 0.0108 0.309
10

ZNF883

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-181b-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-320a;hsa-miR-320c;hsa-miR-335-3p;hsa-miR-33a-3p 13 AKT3 Sponge network -0.096 0.86002 0.4 0.44923 0.3
11

EMX2OS

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-144-3p;hsa-miR-146a-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-3p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-26b-5p;hsa-miR-30e-3p;hsa-miR-32-3p;hsa-miR-331-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-34a-5p;hsa-miR-374a-3p;hsa-miR-576-5p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-93-5p 39 PRKAA2 Sponge network 0.757 0.32745 1.488 0.0108 0.292
12

HCG11

 hsa-let-7a-3p;hsa-miR-130b-3p;hsa-miR-148a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-26b-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p 10 IGF1 Sponge network 0.367 0.56366 0.235 0.63995 0.271
13

EMX2OS

 hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-192-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-21-3p;hsa-miR-26b-5p;hsa-miR-335-5p;hsa-miR-378a-3p;hsa-miR-532-3p;hsa-miR-592;hsa-miR-760;hsa-miR-93-3p 15 RPS6KA2 Sponge network 0.757 0.32745 -0.004 0.9959 0.27
14

ZNF883

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-101-5p;hsa-miR-130b-3p;hsa-miR-148a-5p;hsa-miR-15b-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-320a;hsa-miR-33a-3p;hsa-miR-576-5p 19 IGF1 Sponge network -0.096 0.86002 0.235 0.63995 0.269
15

HCG11

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-10a-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-146a-5p;hsa-miR-146b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-200a-3p;hsa-miR-21-3p;hsa-miR-26a-1-3p;hsa-miR-26b-5p;hsa-miR-338-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-7-1-3p 22 PRKAA2 Sponge network 0.367 0.56366 1.488 0.0108 0.258
16

CECR7

 hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-192-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-26b-5p;hsa-miR-30b-5p;hsa-miR-30d-5p;hsa-miR-335-5p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-532-3p;hsa-miR-592;hsa-miR-760 16 RPS6KA2 Sponge network 0.758 0.26055 -0.004 0.9959 0.258
17

EMX2OS

 hsa-let-7f-1-3p;hsa-miR-148a-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-32-3p;hsa-miR-335-5p;hsa-miR-339-5p;hsa-miR-374b-5p;hsa-miR-576-5p;hsa-miR-582-3p;hsa-miR-590-3p 13 PIK3CA Sponge network 0.757 0.32745 0.179 0.76687 0.254
18

DGCR5

 hsa-let-7f-1-3p;hsa-let-7g-5p;hsa-miR-141-3p;hsa-miR-146a-5p;hsa-miR-15b-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-3p;hsa-miR-26a-2-3p;hsa-miR-30c-5p;hsa-miR-30e-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-576-5p 21 PRKAA2 Sponge network 0.147 0.77174 1.488 0.0108 0.251

Quest ID: 5a44877ff0e60286d17bb9e7bb248efd